Publications & Works

Publication Network
Articles 205
All (205)
SCI-E, SSCI, AHCI (155)
SCI-E, SSCI, AHCI, ESCI (178)
ESCI (23)
Scopus (179)
TRDizin (39)
Other Publications (10)

1. Pilot evaluation of optical genome mapping in chronic lymphocytic leukemia: complementing FISH analysis

Erdem S., Bayrak Tokaç A. G., Aday A., Karaca D., Mutlu M. B., Çefle K., et al.
BMC CANCER , vol.25, no.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. Erratum: Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study.

Ailawadhi S., Špička I., Spencer A., Lu J., Oriol A., Ling S., et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , vol.43, no.27, pp.3056, 2025 (SCI-Expanded) identifier

3. Novel prognostic factor in thrombotic thrombocytopenic purpura: human leukocyte antigen class II

Kikili C. İ., Kivanç D., Ortaboz D., Çiftçi H., Özbalak M., Yenerel M. N., et al.
BLOOD COAGULATION & FIBRINOLYSIS , vol.36, no.6, pp.296-300, 2025 (SCI-Expanded) identifier identifier identifier

4. Graft-Versus-Leukemia Effect in the Management of Isolated Pancreatic Granulocytic Sarcoma Following Allogeneic Stem Cell Transplantation.

Kurt R., Aydin Y., Kalayoglu Besisik S.
Cureus , vol.17, no.8, 2025 (ESCI) identifier

5. Hemophagocytic lymphohistiocytosis syndrome (HLH) in HIV-associated Kaposi sarcoma patients: The first case series from a single center in Türkiye.

Orta Z., Benli A., Çağatay A. A., Başaran S., Erdem S., Beşişik S.
International journal of STD & AIDS , 2025 (SCI-Expanded) identifier identifier

6. Survey of Red Cell Transfusion Therapy and Immunohematology Service for Patients with Hemoglobinopathies in Turkey.

Gürlek Gökçebay D., Andıç N., Flegel W. A., Aygüneş U., Eker I., Gürsel O., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , 2025 (SCI-Expanded) identifier

7. Clinical Manifestations, Treatment Characteristics and Clinical Outcome in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in the Real-World Setting: An Interim Analysis of the Turkish iTTP Registry.

Karakuş S., Bakanay Ş. M., Kalayoğlu Beşişik S., Eşkazan A. E., Ayyıldız O., Gürkan E., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , 2025 (SCI-Expanded) Creative Commons License identifier

8. Transient elastography measurements of the liver and transplanted kidney in patients with AA amyloidosis: a cross-sectional comparative study.

Bektaş M., Çavuş B., Ağargün B. F., Şenkal İ. V., Koca N., İnce B., et al.
Rheumatology international , vol.45, no.7, pp.162, 2025 (SCI-Expanded) identifier identifier

9. Therapeutic plasmapheresis in the management of thyrotoxicosis: a-retrospective study with emphasis on critically ill patients

Mutlu Ü., Bektaş F., Dadın S., Hacişahinoğulları H., İşcan A. Y., Yenidünya Yalın G., et al.
ENDOCRINE , 2025 (SCI-Expanded, Scopus) identifier identifier

10. Isatuximab Subcutaneous by On-Body Delivery System vs Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 3 IRAKLIA Study.

Ailawadhi S., Špička I., Spencer A., Lu J., Oriol A., Ling S., et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2025 (SCI-Expanded) identifier

11. Potential Predictors of the Outcome of Tocilizumab Treatment in Patients with COVID-19-Associated Hyperinflammation

AMIKISHIYEV S., BEKTAŞ M., GÜNVER M. G., İNCE B., Aghamuradov S., Koca N., et al.
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.7, no.2, pp.185-194, 2025 (ESCI) identifier

12. Comparative analysis of five-year clinical outcomes of autologous hematopoietic stem cell transplantation and alemtuzumab in multiple sclerosis patients.

Manazoğlu H. C., İşkan G., Gündüz T., Emekli A. S., Akman G., Altunrende B., et al.
Multiple sclerosis and related disorders , vol.100, pp.106542, 2025 (SCI-Expanded) identifier

13. Evaluation of therapeutic plasma exchange in anti-neutrophil cytoplasmic antibody-associated vasculitis in real-life settings: long-term results of propensity score matching analysis in high-risk patients.

I Nce B., Bektas M., Gülseren Ü. A., Ük E., Çelik B., Yüce S., et al.
Scandinavian journal of rheumatology , pp.1-10, 2025 (SCI-Expanded) identifier

14. Establishing Age-Gender Specific Reference Values of T and B Lymphocyte Subsets in Healthy Adults Using Flow Cytometry

Kaynak F. T., Yanasik M., ÇINAR S., BEŞIŞIK S., DENİZ G., GELMEZ M. Y.
EXPERIMED , 2025 (ESCI) Sustainable Development identifier

15. Are mesenchymal stem cells still effective in acute GvHD management?

Ulu B. U., Hindilerden I. Y., Yigenoglu T. N., Tiryaki T. O., ERKURT M. A., Korkmaz G., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.64, no.1, 2025 (SCI-Expanded) identifier identifier identifier

16. Impact of COVID-19 on Hematologic Disorders: Clinical Insights and Challenges

ERDEM S., SERT EKİNCİ S., ÖZBALAK M. M., MASTANZADE M., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Istanbul Medical Journal , vol.26, 2025 (ESCI)

17. Effect of blood groups on acquired and congenital thrombotic thrombocytopenic purpura and clinical correlation: Multi-center Turkish cohort study

İlteriş Kıkılı C., Ortaboz D., Yanaşık M., AR M. C., Kalayoğlu Beşışık S.
Hematology, Transfusion and Cell Therapy , vol.47, no.1, 2025 (ESCI) identifier identifier

18. Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis-an amazing clue.

Kıkılı C. İ., Kıvanç D., Şentürk Çiftçi H., Özbalak M. M., Yenerel M. N., Nalçacı M., et al.
Hematology, transfusion and cell therapy , vol.47, no.1, pp.103746, 2025 (ESCI) identifier identifier

19. Efficacy of Low-Density Lipoprotein Cholesterol Apheresis in the Treatment of Familial Hypercholesterolemia: Single Center Experience

Hacisahinogullari H., Bilik Oyman G., Mutlu Ü., Dadin S., Yalin G. Y., Soyluk Ö., et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.133, no.2, pp.92-97, 2024 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

20. Central nervous system involvement of mantle cell lymphoma: Case report and review of the literature.

Ağargün B. F., Özbalak M. M., Gülseren Ü. A., Yegen G., Beşışık S.
Hematology, transfusion and cell therapy , vol.46, 2024 (ESCI) identifier identifier

21. Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Facon T., Dimopoulos M., Leleu X. P., Beksac M., Pour L., Hájek R., et al.
The New England journal of medicine , vol.391, no.17, pp.1597-1609, 2024 (SCI-Expanded) identifier identifier

22. Evaluation of the prognostic significance of clinical features of tumoral lesions in an extensive series of mycosis fungoides

Atci T., Ozturk Sari S., Buyukbabani N., Besisik S., Baykal C.
International Journal of Dermatology , vol.63, no.10, pp.1404-1413, 2024 (SCI-Expanded) identifier identifier

23. Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey.

Kıkılı C. İ., Kıvanç D., Ortaboz D., Şentürk Çiftçi H., Özbalak M. M., Yenerel M. N., et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , vol.35, no.6, pp.307-315, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

24. Long-Term Remission After Nelarabine and Donor Lymphocyte Infusion in a Patient With T-ALL Who Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

Koruk K., Tiryaki T. O., ÖZBALAK M. M., MASTANZADE M., Arslan O., BEŞIŞIK S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2024 (SCI-Expanded) identifier

25. Primary Cutaneous Follicle Center Cell Lymphoma, Follicular Type, With High Ki-67 Index Arising on the Forehead

ÇATMA Y., MASTANZADE M., Ozturk S., BEŞIŞIK S.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2024 (SCI-Expanded) identifier

26. Immunosuppression-Based Lymphoproliferative Disease Features and Parameters Affecting Survival

Göktaş Aydın S., Nalçacı M., Yönal Hindilerden İ., Beşışık S., Yenerel M. N.
Genel Tıp Dergisi , vol.34, no.5, pp.671-679, 2024 (Peer-Reviewed Journal)

27. INFECTION EVENTS IN MULTIPLE MYELOMA DURING THE EARLY PERIOD OF AUTOLOGOUS STEM CELL TRANSPLANTATION

AMIKISHIYEV S., BEŞIŞIK S., YÖNAL HİNDİLERDEN İ., YENEREL M. N., ÇAĞATAY A. A., ERDEM S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.87, no.3, pp.246-252, 2024 (ESCI) identifier identifier

28. Assessment of Tp-Te interval in patients with cardiac AL amyloidosis.

Tor Y. B., Habibov I., Altinkaynak M., Aydogan M., Baykiz D., Tayfur M., et al.
Cardiovascular journal of Africa , vol.34, pp.1-5, 2024 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier

29. Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International Multicenter Retrospective B-HOLISTIC Study Suudi Arabistan, Türkiye ve Güney Afrika'daki Hodgkin Lenfoma Hastalarında Tedavi Modelleri ve Klinik Sonuçlar: Uluslararası Çok Merkezli Retrospektif B-HOLISTIC Çalışmasından Alt Grup Analizi

Brittain D., Akhtar S., Rodrigues S., Patel M., Moodley D., Singh J. P., et al.
Turkish Journal of Hematology , vol.41, no.4, pp.211-224, 2024 (SCI-Expanded) Creative Commons License identifier identifier

30. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

Sadri S., Yonal-Hindilerden I., mutlu Y. g., tiryaki t. o., Gemici A., Beköz H. S., et al.
The European Research Journal , vol.9, no.6, pp.1368-1379, 2023 (Peer-Reviewed Journal) Creative Commons License identifier

31. Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.

Dirim A. B., Agargun B. F., Hurdogan O., Ozluk Y., Safak S., Garayeva N., et al.
Journal of nephrology , vol.36, no.8, pp.2381-2385, 2023 (SCI-Expanded) identifier identifier

32. An atypical case of refractory passenger lymphocyte syndrome after renal transplantation.

Dirim A. B., Demir E., Safak S., Garayeva N., Artan A. S., Oto O. A., et al.
Nefrologia , vol.43, no.6, pp.783-788, 2023 (Peer-Reviewed Journal) identifier identifier

33. THE DETERMINANTS IN THE MANAGEMENT OF PREGNANCIES COMPLICATED WITH IMMUNE THROMBOCYTOPENIA

Kunt İşgüder Ç., Saraç Sivrikoz T., Akın M., Törehan M., Uygur L., Birol İnce Ş., et al.
İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası , vol.86, no.4, pp.295-301, 2023 (Peer-Reviewed Journal) Creative Commons License

34. Impact of Epitope Match on Stem Cell Transplantation

ÖGRET Y., TİRYAKİ T. O., Zanjani B. N., İZGİ D., Cinar C. K., Hindilerden I. Y., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023 (SCI-Expanded) identifier

35. Nasopharyngeal plasmacytoma with tumefactive amyloidosis ("amyloidoma") presenting with unilateral hearing loss

SAKCI E., Mastanzade M., Sen B., Sakci Z., Hindilerden I. Y., BEŞIŞIK S.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023 (SCI-Expanded) identifier

36. The gut microbiota changes during multiple myeloma treatment

BEŞIŞIK S., OĞUZ F., ERDEM F., ÖNCÜL M. O., Gurer E. E., Tiryaki T. O., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023 (SCI-Expanded) identifier

37. Cardiac AL amyloidosis experienced in the last decade from a single center

ERDEM S., Mastanzade M., KARACA ÖZER P., ÇETİN O., HACIALİOĞLU A. C., Aydogan M., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023 (SCI-Expanded) identifier

38. P-395 The gut microbiota changes during multiple myeloma treatment

Kalayoglu-Besisik S., Oguz F. S., Aktas Z., Öncül M. O., Gurer E. E., Tiryaki T. O., et al.
CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA , vol.23, pp.258-259, 2023 (Scopus) identifier

39. Baseline inflammation indexes and neutrophil-to-LDH ratio for prediction of the first mobilization failure without plerixafor-based regimens in multiple myeloma and lymphoma patients: A single-center retrospective study.

Dirim A. B., Tiryaki T. O., Altin S., Besisik S., Hindilerden I. Y., Nalcaci M.
Journal of clinical apheresis , 2023 (SCI-Expanded) identifier

40. A comparison of methods of plasmapheresis for the treatment of late antibody mediated rejection in kidney transplant recipients

Caliskan Y., Mirioglu Ş., Dirim A. B., Ozluk Y., Yegit O. O., Aksoy E., et al.
THERAPEUTIC APHERESIS AND DIALYSIS , vol.27, no.3, pp.428-434, 2023 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

41. Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the Pandemic

Amikishiyev S., Gunver M. G., Bektas M., Aghamuradov S., Ince B., Koca N., et al.
ARTHRITIS & RHEUMATOLOGY , vol.75, no.5, pp.664-672, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

42. Independent risk factors for COVID-19-associated coagulopathy

Tor Y., Ozbalak M. M., Kalayoglu-Besisik S., Aksoy E., Cagatay A., Gul A., et al.
European Review for Medical and Pharmacological Sciences , vol.27, no.16, pp.7851-7860, 2023 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

43. Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

Dal M. S., Ulu B. U., UZAY A., Akay O. M., Besisik S., Yenerel M. N., et al.
ANNALS OF HEMATOLOGY , vol.102, no.1, pp.133-140, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

44. Salvage Intrapartum Splenectomy for the Treatment of Transfusion-refractory Anaemia in a ß-thalassemia Intermedia Patient.

Sivrikoz T. S., Ozbalak M., Ozmen A., Tukenmez M., Besisik S. K.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP , vol.32, no.10, pp.1344-1346, 2022 (SCI-Expanded) identifier identifier

45. Blood and bone marrow donor registry of Istanbul medical faculty activity and experience in past 3 years A cross-sectional documentation of TRIS activity: the first blood and marrow registry in Turkey

OĞUZ F., EROL A., ÇINAR Ç., KIVANÇ D., SÜLEYMANOĞLU M., ÖGRET Y., et al.
CELL AND TISSUE BANKING , vol.23, no.3, pp.483-488, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

46. Salvage for Postpartum Massive Haemorrhage in a Jehovah's Witness with Intravenous Iron Therapy and Cell Saver System.

Sivrikoz T. S., Isguder C. K., Canturk M. M., Sungur M. O., Besisik S. K.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP , vol.32, no.9, pp.1202-1204, 2022 (SCI-Expanded) identifier identifier

47. Immune modulation as a consequence of SARS-CoV-2 infection

Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz V., Küçüksezer U. C., Akdeniz N., et al.
FRONTIERS IN IMMUNOLOGY , vol.13, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

48. Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis.

Dirim A. B., Demir E., Guller N., Safak S., Artan A. S., Oto Ö. A., et al.
Journal of clinical apheresis , vol.37, no.4, pp.376-387, 2022 (SCI-Expanded) identifier identifier identifier

49. Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.

Kalayoglu Besisik S., Ozbalak M. M., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
American journal of blood research , vol.12, no.2, pp.54-59, 2022 (Peer-Reviewed Journal) Sustainable Development identifier

50. Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Özbalak M. M., Güzel Mastanzade M., Özlük Ö., Tiryaki T. O., Erdem S., Özbalak E. P., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.4, pp.254-261, 2022 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier identifier

51. Recombination frequencies of human leukocyte antigen loci in hematological malignancies among Turkish population.

ÇINAR Ç., TEMURHAN S., ÖGRET Y., Akgul S. U., Hayriye Senturk C., BEŞIŞIK S., et al.
International journal of laboratory hematology , vol.43, no.6, pp.1432-1436, 2021 (SCI-Expanded) identifier identifier identifier

52. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.

Akay O. M., Ozbalak M. M., Pehlivan M., Yildiz B., Uzay A., Yigenoglu T. N., et al.
Hematological oncology , vol.39, no.4, pp.498-505, 2021 (SCI-Expanded) identifier identifier identifier

53. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study.

Dal M. S., Batgi H., Erkurt M. A., Hindilerden I. Y., Kuku I., Kurtoglu E., et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , vol.60, no.5, pp.103243, 2021 (SCI-Expanded) identifier identifier

54. Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results.

Kuyumcu S., Isik E. G., Tiryaki T. O., Has-Simsek D., Sanli Y., Buyukkaya F., et al.
Annals of nuclear medicine , vol.35, no.10, pp.1147-1156, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

55. Transient Elastography (fibroscan); As a New Non-invasive Diagnostic Method for Detecting Hepatic Involvement of Amyloidosis

BEKTAŞ M., ÇAVUŞ B., AĞARGÜN B. F., Senkal V., KOCA N., İNCE B., et al.
ARTHRITIS & RHEUMATOLOGY , vol.73, pp.2306-2308, 2021 (SCI-Expanded, Scopus) identifier

56. R-CHOP Chemotherapy with a Rituximab Biosimilar (Redditux®) for Patients with de novo Diffuse Large B-cell Lymphoma: First Preliminary Results of a Real-Life Single-Center Experience from Turkey

Özbalak M. M., Mastanzade M., Özlük Ö., Tiryaki T. O., Pınar Özbalak E., Yönal Hindilerden İ., et al.
İstanbul Kanuni Sultan Süleyman Tıp Dergisi , vol.13, no.3, pp.194-198, 2021 (Peer-Reviewed Journal)

57. Comparison of peripheral blood chimerisms to tissue chimerisms in patients with allogeneic heamatopoietic stem cell transplantation

Ozbalak E. P., ÖGRET Y., MASTANZADE M., Hindilerden I. Y., OĞUZ F., BEŞIŞIK S.
EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.358, 2021 (SCI-Expanded) identifier

58. Non-disease-originated leukocyte subset chimerism and the clinical outcome in hematopoetic stem cell transplantation

Mastanzade M., BEŞIŞIK S., ÖGRET Y., OĞUZ F., Hindilerden I. Y., NALÇACI M.
EUROPEAN JOURNAL OF IMMUNOLOGY , pp.367, 2021 (SCI-Expanded) identifier

59. HLA allele and haplotype frequencies in a subset of 456 Turkish patients in the blood and bone marrow donor registry of Istanbul Medical Faculty

OĞUZ F., ÖGRET Y., EROL A., ÇINAR Ç., KIVANÇ D., Ciftci H., et al.
EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.294, 2021 (SCI-Expanded) identifier

60. Frequency of RHD variants in serologically weak D Turkish blood donors

Yanasik M., Oguz F., Besisik S., Huslu M., Ozturk G., Temurhan S., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.2, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

61. Successful treatment of a COVID-19 patient with thrombotic microangiopathy

Safak S., Aksoy E., Dirim A. B., Demir E., Garayeva N., Oto O. A., et al.
CLINICAL KIDNEY JOURNAL , vol.14, no.4, pp.1287-1288, 2021 (SCI-Expanded) Sustainable Development identifier identifier identifier

62. Initial complete blood count score and predicting disease progression in COVID-19 patients.

Ozbalak M. M., Kalayoglu Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
American journal of blood research , vol.11, no.1, pp.77-83, 2021 (ESCI) Sustainable Development identifier

63. Antithrombin, COVID-19, and Fresh Frozen Plasma Treatment Reply

Anakli İ., Ozcan P. E., Polat O., Orhun G., Alay G. H., Tuna V., et al.
TURKISH JOURNAL OF HEMATOLOGY , no.2, pp.158-159, 2021 (SCI-Expanded) identifier

64. Prognostic Value of Antithrombin Levels in COVID-19 Patients and Impact of Fresh Frozen Plasma Treatment: A Retrospective Study

Anaklı İ., Ergin Özcan P., Polat Ö., Orhun G., Alay G. H., Tuna V., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.1, pp.15-21, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development identifier identifier identifier identifier

65. Cytomegalovirus reactivation during adult acute lymphoblastic leukemia maintenance: do we underestimate (un)expected guest of pediatric approach?

Ozbalak M. M., Mastanzade M., GÜREL E., BEŞIŞIK S.
AMERICAN JOURNAL OF BLOOD RESEARCH , vol.11, no.1, pp.118-122, 2021 (ESCI) Sustainable Development identifier

66. Prolonged Severe Watery Diarrhea in a Long-Term Myeloma Survivor: An Unforeseen Infection with Cystoisospora belli

Tiryaki T. O., Anıl K. U., Büyük M., Yıldırım A. Y., Atasoy A., Çiftçibaşı Örmeci A., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.38, no.2, pp.171-173, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development identifier identifier identifier identifier

67. Initial complete blood count score and predicting disease progression in COVID-19 patients

Ozbalak M. M., Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , vol.11, no.1, pp.77-83, 2021 (ESCI) Sustainable Development identifier

68. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG).

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , vol.59, no.4, pp.102827, 2020 (SCI-Expanded) Sustainable Development identifier identifier identifier

69. Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma.

BEKSAÇ M., Aydin Y., GÖKER H., Turgut M., Besisik S., Cagirgan S., et al.
Clinical lymphoma, myeloma & leukemia , vol.20, no.8, 2020 (SCI-Expanded) identifier identifier identifier

70. A challenging disease: Congenital plasminogen deficiency

Ünüvar A., Karaman S., Karakaş Z., Bilici M., Çukurova F., Altınkurt E., et al.
HAEMOPHILIA , vol.26, pp.69-70, 2020 (SCI-Expanded) Creative Commons License identifier

71. Cytokine Gene Polymorphisms and Chromosome 13 Deletion in Multiple Myeloma Patients

Kekik Çınar Ç., Karahan G. E., TEMURHAN S., BEŞIŞIK S., OĞUZ F., AYDIN F.
Sabiad , vol.3, no.3, pp.179-185, 2020 (Peer-Reviewed Journal)

72. Myelomatous Pleural Effusion: A Rare Involvement in Myeloma

Beşışık S.
J of Medical Cases , vol.11, pp.55-56, 2020 (Peer-Reviewed Journal)

73. HOW CAN WE TREAT LIGNEOUS CONJUNCTIVITIS IN HEREDITARY PLASMINOGEN DEFICIENCY?

Tugcu D., Karaman S., Tuna R., Bilici M., Altinkurt E., Cukurova F., et al.
HAEMOPHILIA , pp.149, 2020 (SCI-Expanded) identifier

74. Retrospective Analysis of Peripheral T-Cell Lymphoma Patients: Single Center 'Real-Life' Experience

Ozbalak M. M., MASTANZADE M., Ozluk O., TİRYAKİ T. O., Hindilerden I. Y., YENEREL M. N., et al.
MEDICAL JOURNAL OF BAKIRKOY , vol.16, no.4, pp.392-398, 2020 (ESCI) Creative Commons License identifier

75. The Overall Distribution of ABO and Rh (D) Groups in The Most Populous City Istanbul as Representing the Complex Ethnicity of Turkey

YANAŞIK M., TUNÇ T., Huslu M., BEŞIŞIK S.
MEDICAL JOURNAL OF BAKIRKOY , vol.16, no.4, pp.363-368, 2020 (ESCI) identifier

76. A practical 16-day desensitization protocol in lenalidomide-induced non-immediate hypersensitivity reactions

Demir S., Gelincik A., Coskun R., Ozkan G., Demir N., Paksoy N., et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY , vol.123, no.4, pp.394-397, 2019 (SCI-Expanded) identifier identifier identifier

77. Remembering the Basics: A Patientwith Sickle Cel Disease and Proteinuria

Beşışık S.
TURKISH JOURNAL OF NEPHROLOGY , vol.28, pp.154-156, 2019 (Scopus)

78. Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Study

Hindilerden I. Y., Erciyestepe M., Nalcaci M., Kalayoglu-Besisik S., Sargin D., Aktan M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, 2019 (SCI-Expanded) identifier

79. The Turkish experience with therapeutic plasma exchange: A national survey

Korkmaz S., Medeni S. S., DEMİRKAN F., Besisik S., Dadin S. A., ÇAĞLIYAN G. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.58, no.3, pp.287-292, 2019 (SCI-Expanded) identifier identifier identifier

80. ; The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma

Sakai B., Sayitoglu M., Istemihan Z., Karan M. A., Erten N., Dogan O., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.3, pp.178-185, 2019 (SCI-Expanded) identifier identifier identifier identifier

81. Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis

Sariman M., Abaci N., Ekmekci S., Cakiris A., Pacal F., Ustek D., et al.
Balkan medical journal , vol.36, no.1, pp.23-31, 2019 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

82. Orak Hücreli Anemili Hastada Akut Göğüs Sendromu: Vaka Sunumu ve Literatürün Gözden Geçirilmesi

Beşışık S.
Çocuk Dergisi , vol.19, no.1, pp.37-42, 2019 (Peer-Reviewed Journal)

83. Remembering the Basics: A Patient with Sickle Cell Disease and Proteinuria

Ozbalak E. P., Mirioglu Ş., Sahin E., Ozluk Y., Ucar A. R., Yazici H., et al.
TURKISH JOURNAL OF NEPHROLOGY , vol.28, no.2, pp.154-156, 2019 (ESCI) Sustainable Development identifier identifier identifier

84. Short Tandem Repeat-Polymerase Chain Reaction (STR-PCR) with Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) Method Using for Chimerism Analysis

Abatay-Sel F., Savran-Oguz F., Kalayoglu-Besisik S., Mastanzade M., Duvarci-Ogret Y., Yonal-Hindilerden I., et al.
CLINICAL LABORATORY , vol.65, no.9, pp.1697-1703, 2019 (SCI-Expanded) identifier identifier identifier

85. Türkiye Klinikleri

Beşışık S.
Türkiye Klinikleri , vol.1, no.1, pp.53-58, 2019 (Peer-Reviewed Journal)

86. The use of emergency apheresis in the management of plasma cell disorders

Kalayoglu-Besisik S.
TRANSFUSION AND APHERESIS SCIENCE , vol.57, no.1, pp.35-39, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

87. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)

Tekgunduz E., DEMİRKAN F., VURAL F., GÖKER H., Ozdogu H., KİKİ İ., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.56, no.6, pp.804-808, 2017 (SCI-Expanded) identifier identifier identifier

88. Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma

Witzig T. E., Zinzani P. L., Habermann T. M., Tuscano J. M., Drach J., Ramchandren R., et al.
AMERICAN JOURNAL OF HEMATOLOGY , vol.92, no.10, 2017 (SCI-Expanded) identifier identifier identifier

89. Akut Graft Versus Host Hastalığı

Beşışık S.
Turkiye Klinikleri , vol.10, no.4, pp.221-227, 2017 (Peer-Reviewed Journal)

90. Lichen myxedematosus: a case series focusing on clinical features, disease associations, and management.

Atci T., Yazganoglu K. D., Yonal I., Ekinci A. P., Kaplan S. G., Babuna G., et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , vol.15, no.2, pp.215-218, 2017 (SCI-Expanded) identifier identifier identifier

91. Lichen myxedematosus: eine Fallserie mit Schwerpunkt auf klinischen Merkmalen, Krankheitsassoziationen und Behandlung.

Atci T., Yazganoglu K., Yonal I., Ekinci A., Kaplan S., Babuna G., et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , vol.15, pp.214-217, 2017 (SCI-Expanded) identifier identifier

92. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011.

Yonal-Hindilerden I., Kalayoglu-Besisik S., Gurses-Koc N., Hindilerden F., Sargin D.
International journal of hematology-oncology and stem cell research , vol.11, pp.58-62, 2017 (Scopus) identifier identifier

93. Impact of HLA-DPB1 Matching in Unrelated Allogeneic Stem Cell Transplantation: Results of Two Centers From Turkey

Kantarcioglu B., Bekoz H. S., Hindilerden I. Y., Kivanc D., Ogret Y., Besisik S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27, no.2, pp.74-84, 2017 (SCI-Expanded) identifier identifier identifier

94. An Unexpected Innocent Complication Associated with Azacitidine Treatment of Myelodysplastic Syndrome: Erythema Annulare Centrifugum.

Erkek E. T., Besisik S.
Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.33, no.1, pp.81-2, 2016 (SCI-Expanded) identifier identifier identifier

95. A Rare Cause of Unexplained Refractory Iron Deficiency Anemia: Unicentric Plasma-Cell Type Castleman's Disease

Besisik S., Hindilerden I. Y., Hindilerden F., Dogan I. O., Besisik F.
TURKISH JOURNAL OF HEMATOLOGY , vol.33, no.3, pp.257-258, 2016 (SCI-Expanded) identifier identifier identifier

96. Treatment of Vaginal Agglutination Complicating Chronic Graft-Versus-Host Disease: A Rare Case Report

Akhan S. E., Delier H., Bastu E., Yasa C., Ugurlucan F. G., Kalayoglu-Besisik S.
JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , vol.6, pp.626-628, 2015 (ESCI) identifier

97. Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.

Goy A., Kalayoglu Besisik S., Drach J., Ramchandren R., Robertson M. J., Avivi I., et al.
British journal of haematology , vol.170, no.4, pp.496-503, 2015 (SCI-Expanded) identifier identifier identifier

98. Plasmapheresis/immunoadsorption in patients with pemphigus

Kucukoglu R., Erdem Y., Besisik S.
TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY , vol.49, no.1, pp.7-12, 2015 (ESCI) identifier identifier

99. Hematological aftermath of the radiation accident in Istanbul.

Engin V. S., Tufan F., Besisik S., Engin G., Ozturk M., ERSOY S.
International journal of radiation biology , vol.91, no.9, pp.724-31, 2015 (SCI-Expanded) identifier identifier identifier

100. Efficacy, Safety and Responder Subanalysis of Lenalidomide in Heavily Pretreated, Relapsed/Refractory Patients With Mantle Cell Lymphoma Post-Bortezomib: Phase II MCL-001 "EMERGE" Study

Goy A., Williams M. E., Besisik S., Drach J., Ramchandren R., Zhang L., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.14, 2014 (SCI-Expanded) identifier

101. Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1).

Akan H., Aydin S. O., Saltoglu N., Cagatay A., Akalin H., Arat M., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.31, no.2, pp.111-20, 2014 (SCI-Expanded) identifier identifier identifier

102. TÜRKİYE’DE MULTİPL MYELOM’LU HASTALARDA GLUTATYON-S-TRANSFERAZ VE SİTOKROM P450 ENZİMİ GEN POLİMOFİZMİ İLİŞKİSİ

Sarybayev M., Beşışık S.
Tez , vol.2013, pp.1-68, 2013 (Non Peer-Reviewed Journal) Creative Commons License

103. Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Goy A., Sinha R., Williams M. E., Besisik S., Drach J., Ramchandren R., et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , vol.31, no.29, pp.3688-95, 2013 (SCI-Expanded) identifier identifier identifier

104. Multicenter analyses demonstrate significant clinical effects of minor Histocompatibility Antigens on GvHD and GvL after HLA-matched related and unrelated Hematopoietic stem cell transplantation

Spierings E., KIM Y., HENDRIKS M., Borst E., SERGEANT R., CANOSSI A., et al.
Biology of Blood and Marrow Transplantation , vol.19, no.8, pp.1244-1253, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

105. SINGLE-AGENT LENALIDOMIDE IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: A COMBINED ANALYSIS FROM THE MCL-001, NHL-002, AND NHL-003 STUDIES

Witzig T., Vose J., Zinzani P., Habermann T., Tuscano J., Sinha R., et al.
HAEMATOLOGICA , vol.98, pp.130-131, 2013 (SCI-Expanded) identifier

106. Extranodal malt lymphoma presenting with isolated hard palate involvement a diagnostic challenge

KAZANCIOĞLU H. O., ATAY K., AK G., TUFAN F., DOĞAN İ. Ö., BEŞIŞIK S., et al.
Current research in dental sciences (Online) , vol.23, no.2, pp.244-246, 2013 (Peer-Reviewed Journal)

107. Therapeutic apheresis for severe hypertriglyceridemia in pregnancy.

Basar R., Uzum A. K., Canbaz B., Dogansen S. C., Kalayoglu-Besisik S., Altay-Dadin S., et al.
Archives of gynecology and obstetrics , vol.287, no.5, pp.839-43, 2013 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

108. Leukemic ascites as an initial presentation of acute myelomonocytic leukemia with inversion of chromosome 16.

Yonal I., Kayar Y., Nazligul E., Yenerel M. N., Kalayoglu-Besisik S.
Annals of Saudi medicine , vol.33, no.2, pp.197-8, 2013 (SCI-Expanded) identifier identifier identifier

109. Massive ascites as the initial manifestation of mantle cell lymphoma: A challenge for the gastroenterologist

Yonal I., Ciftcibasi A., Gokturk S., Yenerel M. N., Akyuz F., Karaca C., et al.
Case Reports in Gastroenterology , vol.6, no.3, pp.803-809, 2012 (Scopus) identifier identifier

110. Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review.

Elcioglu O. C., Ozkok A., Akpinar T. S., Tufan F., Sezer M., Umman S., et al.
International journal of hematology , vol.96, no.3, pp.370-5, 2012 (SCI-Expanded) identifier identifier identifier

111. GUILLAIN-BARRE SYNDROME AFTER STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE

Muftuoglu M., Osmanbasoglu E., Kalayoglu-Besisik S., Sargin F.
HAEMATOLOGICA , vol.97, pp.728, 2012 (SCI-Expanded) identifier

112. SECONDARY CANCERS FOLLOWING STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

Muftuoglu M., Gurses N., Sargin F., Kalayoglu-Besisik S.
HAEMATOLOGICA , vol.97, pp.721, 2012 (SCI-Expanded) Sustainable Development identifier

113. Bacillus Cereus Catheter Related Bloodstream Infection in a Patient with Acute Lymphoblastic Leukemia

Gurler N., Oksuz L., Muftuoglu M., Sargin F., Besisik S.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.4, no.1, 2012 (ESCI) identifier identifier identifier

114. Plasmacytoma of the nasolacrimal duct simulating dacryocystitis: An uncommon presentation for extramedullary relapse of multiple myeloma

Kalayoglu-Besisik S., Yonal I., Hindilerden F., Agan M., Sargin D.
Case Reports in Oncology , vol.5, no.1, pp.119-124, 2012 (ESCI) identifier identifier identifier

115. Erdheim Chester disease presenting as slowly progressive cerebellar syndrome and asymptomatic widespread skeletal involvement

Tufan F., Myftiu B., Aygun D., Keles N., Haroche J., Hanagasi H. A., et al.
EUROPEAN JOURNAL OF NEUROLOGY , vol.18, no.8, 2011 (SCI-Expanded) identifier identifier identifier

116. TRANSFUSION RELATED ACUTE LUNG INJURY

Kalayoglu-Besisik S., Karahan G., Ozturk G., Tufan F., Oguz F., Sargin D.
NOBEL MEDICUS , vol.7, no.2, pp.110-113, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

117. DETECTION OF CHROMOSOMAL ABNORMALITIES ON INTERFACE CELLS FROM MYELOID LEUKEMIAS BY FISH

Ozdilli K., Aydin F., Besisik S., Oguz F., Temurhan S., Cako O., et al.
NOBEL MEDICUS , vol.6, no.3, pp.84-89, 2010 (SCI-Expanded) Sustainable Development identifier identifier

118. The evaluation of the incidence of recurrent aphthous lesions in patients with haematinic deficiencies

Koray M., Erden S., Ofluoglu D., Ozgul M., Kalayoglu-Besisik S., Tanyeri H.
ORAL DISEASES , no.6, pp.545, 2010 (SCI-Expanded) identifier

119. Folic Acid and Vitamin B12 Supplementation Improves Coronary Flow Reserve in Elderly Subjects with Vitamin B12 Deficiency

Kurt R., YILMAZ Y., Ermis F., Besisik S., Polat N., Elitok A., et al.
Archives of Medical Research , vol.41, no.5, pp.369-372, 2010 (SCI-Expanded) identifier identifier identifier

120. The predictive value of stimulation index calculated by modified mixed lymphocyte culture in the detection of GVHD following hematopoietic stem cell transplantation Hematopoetik kök hücre naklini takiben gelişen GVHD'nin saptanmasında modifiye mikst lenfosit kültür testinde hesaplanan stimülasyon indeksinin belirleyici deg̈eri

Sen H. S., Ayna T. K., Ciftci H. S., Besisik S., Onal E. A., Akcay A., et al.
Turkish Journal of Hematology , vol.27, no.4, pp.263-268, 2010 (SCI-Expanded) identifier identifier identifier

121. Hyperbaric oxygen: An important treatment modality in severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

Yenerel M. N., Kalayoglu-Besisik S., Perdeci O., Gurses N., Tunc M., Sargin D.
Turkish Journal of Hematology , vol.26, no.4, pp.176-180, 2009 (SCI-Expanded) identifier identifier identifier

122. Amyloid arthropathy mimicking seronegative rheumatoid arthritis in multiple myeloma: case reports and review of the literature

Alpay N., Artim-Esen B., Kamali S., Gül A., Kalayoglu-Besisik S.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS , vol.16, no.4, pp.226-231, 2009 (SCI-Expanded) identifier identifier identifier

123. Relationship Between HLA Tissue Type, CMV Infection, and Acute Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Single-Center Experience

Kekik Ç., Besisik S., Seyhun Y., Oguz F., Sargin D., Carin M. N.
TRANSPLANTATION PROCEEDINGS , vol.41, no.9, pp.3859-3862, 2009 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

124. Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia

Palanduz S., Bayrak A., Sirma S., Vural B., Cefle K., Ucur A., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS , vol.13, no.5, pp.599-602, 2009 (SCI-Expanded) identifier identifier identifier

125. Neoangiogenesis after direct intramyocardial implantation of bone marrow-derived stem cells in a patient with severe coronary artery disease ineligible for percutaneous or surgical revascularization

Harmandar B., Tansel T., Onursal E., Gurses N., Besisik S., Sargin D.
Central European Journal of Medicine , vol.4, no.3, pp.279-285, 2009 (SCI-Expanded) identifier identifier identifier

126. Bone Marrow Renin-Angiotensin System in Multiple Myeloma

SAKA B., DOGAN O., TASCIOGLU C., BESISIK S., KARAN M. A., Sayitoglu M., et al.
CLINICAL LYMPHOMA & MYELOMA , vol.9, 2009 (SCI-Expanded) identifier

127. SOLUBLE TRANSFERRIN RECEPTOR AND SOLUBLE TRANSFERRIN RECEPTOR-FERRITIN INDEX FOR EVALUATION OF THE IRON DEFICIENCY IN CIRRHOTIC PATIENTS

Saka B., Erten N., Besisik S., Genc S., Sivas A., Karan M. A., et al.
NOBEL MEDICUS , no.1, pp.19-23, 2009 (SCI-Expanded) Sustainable Development identifier identifier

128. Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: results of 18-month follow-up

Tayyareci Y., UMMAN B., SEZER M., BEŞIŞIK S., ŞANLI Y., MUDUN A., et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.36, no.8, pp.519-529, 2008 (ESCI) identifier identifier identifier

129. Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: Results of 18-month follow-up İskemik kardiyomiyopatili hastalarda intrakoroner otolog kemik iliǧi kaynakli mononükleer kök hücre nakli: 18 Aylik takip sonuçlari

Tayyareci Y., Umman B., Sezer M., Beşişik S., Şanli Y., Mudun A., et al.
Turk Kardiyoloji Dernegi Arsivi , vol.36, no.8, pp.519-529, 2008 (SCI-Expanded) identifier identifier

130. Pulmonary adenocarcinoma coexisting with multiple myeloma

Kocabay G., Erten N., Tiryaki B., Saka B., Taşçioǧlu C., Kalayoǧlu Beşişik S.
Tuberkuloz ve Toraks , vol.56, no.3, pp.369-370, 2008 (SCI-Expanded) identifier identifier

131. The clinical and pharmacoeconomic analysis of invasive aspergillosis in adult patients with haematological diseases

Cagatay A. A., COSAN F., Karadeniz A. N., Besisik S., Ozsut H., Nalcaci M., et al.
Mycoses , vol.51, no.4, pp.328-335, 2008 (SCI-Expanded) Sustainable Development identifier identifier identifier

132. Tissue chimerism analysis after donor lymphocyte infusion: a case of deceptive evidence.

Kalayoglu-Besisik S., Oguz F. S., Aydin F., Duvarci Y., Sargin D., Carin M.
Hematology (Amsterdam, Netherlands) , vol.13, no.2, pp.92-4, 2008 (SCI-Expanded) identifier identifier identifier

133. Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit Kemik iliǧi nakli ünitesinde yatan üç olguda nozokomiyal solunum sinsityal virus enfeksiyonu

Besisik S., Sen F., Midilli K., Yilmaz G., Oezsuet H., Calangu S., et al.
Mikrobiyoloji Bulteni , vol.42, no.2, pp.359-364, 2008 (SCI-Expanded) identifier identifier identifier

134. Intracoronary autologous bone marrow-derived mononuclear cell transplantation improves coronary collateral vessel formation and recruitment capacity in patients with ischemic cardiomyopathy: A combined hemodynamic and scintigraphic approach

Tayyareci Y., Sezer M., Umman B., Besisik S., Mudun A., Sanli Y., et al.
ANGIOLOGY , vol.59, no.2, pp.145-155, 2008 (SCI-Expanded) identifier identifier identifier

135. Primary biliary cirrhosis and IgG-kappa type multiple myeloma both respond well to vincristine, adriamycin and dexamethasone: Is there a pathogenic relationship?

Saka B., Kalayoglu-Besisik S., Ozturk G. B., Dogan O., Erten N.
Journal of the Formosan Medical Association , vol.107, no.2, pp.185-190, 2008 (SCI-Expanded) identifier identifier identifier

136. The Relationship Between Minor Histocompatibility Antigens And Graft-Versus-Host Disease After The Allogeneic Hematopoietic Stern Cell Transplantation

Kekik Ç., Besisik S., Sargin D., Carin M. N., Oguz F., Seyhun Y.
EUROPEAN JOURNAL OF THERAPEUTICS , vol.14, no.1, pp.1-4, 2008 (ESCI) identifier

137. Allojenik hematopoetik kök hücre naklinden sonra graft versus host hastalığı ve minör histokompatibilite antijenleri arasındaki ilişki: Ön Rapor

ÇINAR Ç., BEŞIŞIK S., SEYHUN Y., OĞUZ F., SARGIN F. D., ÇARİN M.
Gaziantep Üniversitesi Dergisi , no.14, pp.1-4, 2008 (Peer-Reviewed Journal)

138. Immunoglobulin D lambda multiple myeloma and amyloidosis with predominant soft tissue involvement

Bahat G., Erten N., Saka B., Uzun S., Onur I., Kalayoglu-Besisik S., et al.
Amyloid , vol.14, no.4, pp.305-308, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

139. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: Correlation with MRI and other prognostic factors

Erten N., Saka B., Berberoğlu K., Türkmen C., Unal S. N., Bakır B., et al.
Annals of Hematology , vol.86, no.11, pp.805-813, 2007 (SCI-Expanded) identifier identifier identifier

140. Inflammatory pseudotumor following hematopoietic stem cell transplantation: a new case and review of the literature

BAHAT G., KALAYOGLU-BESISIK S., OZTURK S., Kilicaslan I., TUNC M., SARGIN D.
BONE MARROW TRANSPLANTATION , vol.40, no.10, pp.915-918, 2007 (SCI-Expanded) identifier identifier identifier

141. Long-term outcome of Nephrotic syndrome in an allogeneic hematopoietic stem cell recipient without typical features of graft versus host disease [5]

KALAYOGLU-BESISIK S., YURCI A., Yazici H., YONAL I., SARGIN D.
Transplantation , vol.83, no.10, pp.1407-1408, 2007 (SCI-Expanded) identifier identifier identifier

142. Determination of cytokine gene polymorphisms in Turkish petients with Multiple myeloma

ÇINAR Ç., BEŞIŞIK S., OĞUZ F., SEYHUN Y., KARAHAN G. E., GÜRTEKİN M., et al.
Adv Mol Med , no.3, pp.189-195, 2007 (Peer-Reviewed Journal)

143. The autologous hematopoietic stem cell transplantation in adult patients with lymphoma: Turkish Bone Marrow Transplantation Registry results

Arpaci F., Ataergin S., Gürman G., Çaǧirgan S., Arat M., Özet A., et al.
Turkish Journal of Cancer , vol.37, no.2, pp.45-53, 2007 (Scopus) identifier

144. Hyperthyroidism in molar pregnancy: Rapid preoperative preparation by plasmapheresis and complete improvement after evacuation

AZEZLI A., BAYRAKTAROGLU T., Topuz S., KALAYOGLU-BESISIK S.
Transfusion and Apheresis Science , vol.36, no.1, pp.87-89, 2007 (SCI-Expanded) Sustainable Development identifier identifier identifier

145. Autologous stem cells collected after debulking by high dose chemotherapy in late phase chronic myeloid leukemia may improve Imatinib efficacy

Kalayoglu-Besisik S., Ozturk G. B., Caliskan Y., Nalcaci M., Gurses N., Cin N., et al.
Transfusion and Apheresis Science , vol.36, no.1, pp.91-94, 2007 (SCI-Expanded) identifier identifier identifier

146. CLINICAL FOLLOW-UP AND TREATMENT RESPONSE OF THE 162 PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA

YENEREL M. N., Atamer T., Ayer M., Yildirim N. D., Kucukkaya R. D., Yavuz A. S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.70, no.1, pp.6-10, 2007 (ESCI) identifier

147. CYTOMEGALOVIRUS INFECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: THE CHANGE IN CLINICAL PICTURE, DIAGNOSIS, AND TREATMENT MODALITY

Arpaci E., Besisik S.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.70, no.2, pp.51-55, 2007 (ESCI) identifier

148. Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation

Caliskan Y., Besisik S., Sargin D., Ecder T.
Bone Marrow Transplantation , vol.38, no.2, pp.141-147, 2006 (SCI-Expanded) identifier identifier identifier

149. Kappa light chain myeloma with initial cutaneous involvement

SAKA B., ERTEN N., OZTURK G., YILMAZ C., DOGAN O., Buyukbabani N., et al.
Annals of Hematology , vol.85, no.4, pp.272-274, 2006 (SCI-Expanded) identifier identifier identifier

150. Preliminary results of intracoronary transplantation of bone marrow-derived progenitor cells evaluated with myocardial perfusion SPECT

Sanli Y., Mudun A., Turkmen C., Tokmak H., Tamam M., Tayyareci Y., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.32, 2005 (SCI-Expanded) identifier

151. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years

Kalayoglu-Besisik S., Yenerel M. N., Caliskan Y., Ozturk S., Besisik F., Sargin D.
TRANSPLANTATION PROCEEDINGS , vol.37, no.5, pp.2285-2289, 2005 (SCI-Expanded) Sustainable Development identifier identifier identifier

152. Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange

Kalayoglu Besisik S., Bahat Öztürk G., Çalişkan Y., Sargin D.
Turkish Journal of Gastroenterology , vol.16, no.1, pp.34-37, 2005 (SCI-Expanded) identifier identifier

153. ERYTHROCYTE SEDIMENTATION RATE

Besisik S.
NOBEL MEDICUS , vol.1, no.1, pp.4-8, 2005 (ESCI) Sustainable Development identifier identifier

154. Acute renal failure due to leukaemic infiltration in chronic lymphocytic leukaemia: Case report

ERTEN N., SAKA B., CALISKAN Y., BESISIK S., Karan M. A., TASCIOGLU C.
International Journal of Clinical Practice , vol.59, pp.53-55, 2005 (SCI-Expanded) Sustainable Development identifier identifier identifier

155. Diffuse alveolar hemorrhage associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation

Kalayoglu Besisik S., Yenerel M. N., Diz Küçükkaya R., Çalişkan Y., Sargin D.
Turkish Journal of Haematology , vol.21, no.4, pp.197-201, 2004 (SCI-Expanded) identifier identifier

156. Intracoronary stem cell implantation during post myocardial infarction period - A case report Miyokard infarktüsü sonrasi intrakoroner kök hücre implantasyonu-vaka bildirimi

Nişanci Y., Olcay A., Umman B., Sezer M., Besişik S., Gürses N., et al.
Anadolu Kardiyoloji Dergisi , vol.4, no.4, pp.348-350, 2004 (SCI-Expanded) identifier identifier

157. Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated

Ozbey N., Kalayoglu-Besisik S., Gul N., Bozbora A., Sencer E., Molvalilar S.
International Journal of Clinical Practice , vol.58, no.6, pp.554-558, 2004 (SCI-Expanded) Sustainable Development identifier identifier identifier

158. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients

Erten N., Genc S., Besisik S., Saka B., Karan M. A., Tascioglu C.
Journal of the Chinese Medical Association , vol.67, no.5, pp.217-221, 2004 (SCI-Expanded) identifier identifier

159. Soluble transferrin receptor and soluble transferrin receptor-ferritin index for evaluation of the iron status in elderly patients

GENC S., ERTEN N., Karan M. A., BESISIK S., SAKA B., TASCIOGLU C., et al.
Tohoku Journal of Experimental Medicine , vol.202, no.2, pp.135-142, 2004 (SCI-Expanded) identifier identifier identifier

160. Methylenetetrahydrofolate reductase C677T polymorphism and toxicity in allogeneic hematopoietic cell transplantation [5]

Kalayoglu-Besisik S., Caliskan Y., Sargin D., Gurses N., Ozbek U.
Transplantation , vol.76, no.12, pp.1775-1777, 2003 (SCI-Expanded) identifier identifier identifier

161. The outcome of large B-cell lymphoma evolving in a hematopoietic stem cell transplant patient during treatment of chronic graft-versus-host disease

Kalayoǧlu K., Kocaman O., Erer B., Yenerel M. N., Doǧan Ö., Sargin D.
Turkish Journal of Haematology , vol.20, no.3, pp.171-174, 2003 (SCI-Expanded) identifier

162. Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis.

Kalayoglu-Besisik S., Abdul-Rahman I., Erer B., Yenerel M. N., Oguz F., Tunc M., et al.
The Journal of urology , vol.170, no.3, pp.922, 2003 (SCI-Expanded) Sustainable Development identifier identifier identifier

163. HLA system affects the age-at-onset in chronic myeloid leukemia

Oguz F., KALAYOGLU S., DILER A. S., TOZKIR H., SARGIN D., CARIN M. N., et al.
American Journal of Hematology , vol.73, no.4, pp.256-262, 2003 (SCI-Expanded) identifier identifier identifier

164. Role of pretransplant interferon-α(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): Results from three Turkish transplant centers

Beksac M., Celebi H., Sargin D., Yalcin A., Topcuoglu P., Kalayoglu-Besisik S., et al.
Bone Marrow Transplantation , vol.31, no.10, pp.897-904, 2003 (SCI-Expanded) identifier identifier identifier

165. Cyclosporine-associated hyperkalemia: Report of four allogeneic blood stem-cell transplant cases

Caliskan Y., Kalayoglu-Besisik S., Sargin D., Ecder T.
Transplantation , vol.75, no.7, pp.1069-1072, 2003 (SCI-Expanded) identifier identifier identifier

166. Major Depression and Psoriasis Activation Due to Interferon-α in a Patient With Chronic Myeloid Leukemia; "Overlooked and/or Misdiagnosed Adverse Reaction In Malignant Disease" [1]

Besisik S., Kocabey G., Caliskan Y.
American Journal of Hematology , vol.74, no.3, pp.224, 2003 (SCI-Expanded) identifier identifier identifier

167. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study

Yeneral M. N., Atamer T., YAVUZ A. F., Kucukkaya R., BEŞIŞIK S., Aktan M., et al.
ANNALS OF HEMATOLOGY , vol.81, no.9, pp.498-503, 2002 (SCI-Expanded) identifier identifier identifier

168. A single center's ten year experience of multiple myeloma patients presenting with renal failure.

Kazancioglu R., Gulsen M., Besisik S., Dogan O., Kilicaslan I., Ecder T.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , vol.13, 2002 (SCI-Expanded) identifier

169. A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL

DORAK M., OGUZ F., Yalman N., DILER A. S., KALAYOGLU S., ANAK S. S., et al.
Leukemia Research , vol.26, no.7, pp.651-656, 2002 (SCI-Expanded) identifier identifier identifier

170. The value of TNF-alpha and IL-10 gene polymorphisms in the incidence and severity of graft-versus-host disease

ÖZBEK U., GURSES N., KALAYOGLU-BESISIK S., Aydin M., BILGEN H., ONGOREN S., et al.
BONE MARROW TRANSPLANTATION , vol.29, 2002 (SCI-Expanded) identifier

171. Favorable outcome of isolated membranous nephropathy in an allogeneic stem cell recipient

Kalayoglu-Besisik S., Yurci A., Yenerel M. N., KAZANCIOĞLU R., Turkmen A., Kilicarslan Y., et al.
BONE MARROW TRANSPLANTATION , vol.29, 2002 (SCI-Expanded) identifier

172. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: A single center study.

Yenerel M. N., Atamer T., Yavuz A., Kucukkaya R., Besisik S., Aktan M., et al.
BLOOD , vol.98, no.11, 2001 (SCI-Expanded) identifier

173. HHV-8 is not ubiquitus in Turkish multiple myeloma patients as determined by nested-PCR and also serological analysis.

Torun A., Kalayoglu-Besisik S., Ozkan E., Basaran P., Yenerel M. N., Karan M., et al.
BLOOD , vol.98, no.11, 2001 (SCI-Expanded) identifier

174. Thrombotic complications in essential thrombocythemia.

Atamer T., Yenerel M. N., Yavuz A., Kucukkaya R., Besisik S., Aktan M., et al.
BLOOD , vol.98, no.11, 2001 (SCI-Expanded) identifier

175. Cytokine gene polymorphism in patients with graft-versus-host disease after HLA-matched bone marrow transplantion.

ÖZBEK U., GURSES N., KALAYOGLU-BESISIK S., Aydin M., BILGEN H., ONGOREN S., et al.
BLOOD , vol.98, no.11, 2001 (SCI-Expanded) identifier

176. A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk childhood ALL.

Dorak M., Oguz F., Yalman N., Diler A., Kalayoglu S., Anak S., et al.
BLOOD , vol.98, no.11, 2001 (SCI-Expanded) identifier

177. Paroxysmal nocturnal hemoglobinuria clone in patients with myelodysplastic syndrome

Yenerel M. N., Diz-Kucukkaya R., Besisik S., Aktan M., Nalcaci M., Dincol G., et al.
AMERICAN JOURNAL OF HEMATOLOGY , vol.68, no.1, pp.64-65, 2001 (SCI-Expanded) identifier identifier identifier

178. Akut Lösemi ve Aplastik anemide HLA-DRB alelleri

OĞUZ F., DİLER A. S., BEŞIŞIK S., ÇINAR Ç., SEYHUN Y., ANAK S. S., et al.
GÜLHANE TIP DERGİSİ , no.43, pp.312-315, 2001 (Scopus)

179. Chimerism status in allo-pbsct versus allo-BMT: single center results

Uzbek U., Kalayoglu-Besisik S., Aydin M., Yenerel M. N., Aktan M., Budak T., et al.
Blood , vol.96, 2000 (SCI-Expanded) identifier

180. Chimerism status in allo-PBSCT versus allo-BMT: Single center results.

Özbek U., Kalayoglu-Besısık S., Aydin M., Yenerel M. N., Aktan H., Budak T., et al.
BLOOD , vol.96, no.11, 2000 (SCI-Expanded) identifier

181. National survey of hemapheresis practice in Turkey (1998)

Ilhan O., Uskent N., Arslan O., Arat M., Ozkalemkas F., Ozturk G., et al.
TRANSFUSION SCIENCE , vol.22, no.3, pp.195-201, 2000 (SCI-Expanded) identifier identifier identifier

182. The influence of flow cytometric gating strategy and cell preparation procedures on CD34(+) cell quantification

Yenerel M. N., Budak-Alpdogan T., Kalayoglu-Besisik S., Yanasik M., Sargin D.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH , vol.9, no.1, pp.11-12, 2000 (SCI-Expanded) identifier identifier identifier

183. The Frequency of Tuberculosis in Adult Allogeneic Stem Cell Transplant Recipients in Turkey

Budak-Alpdogan T., Tangun Y., Kalayoglu-Besisik S., Ratip S., Akan H., Baslar Z., et al.
Biology of Blood and Marrow Transplantation , vol.6, no.4, pp.370-374, 2000 (SCI-Expanded) Sustainable Development identifier identifier identifier

184. Iron deficiency anemia of unknown etiology and/or resistance to the treatment: The sole manifestation of adult celiac disease (CD) [5]

YENEREL M. N., Kalayoglu-Besisik S.
American Journal of Hematology , vol.61, no.2, pp.156-157, 1999 (SCI-Expanded) identifier identifier

185. Iron deficiency anemia of unknown etiology and or resistance to the treatment: The sole manifestation of adult celiac disease (CD)

Yenerel M. N., Kalayoglu-Besisik S.
AMERICAN JOURNAL OF HEMATOLOGY , vol.61, no.2, pp.156-157, 1999 (SCI-Expanded) identifier

186. The prevalence of tuberculosis (TBC) in adult allogeneic stem cell transplant recipients in Turkey.

Budak T., Besisik S., Akan H., Baslar Z., Ratip S., Koc H., et al.
BONE MARROW TRANSPLANTATION , vol.23, 1999 (SCI-Expanded) Sustainable Development identifier

187. The source of stem cells (BMT versus PBSCT) in adult allogeneic transplantation does not only predict the incidence of chronic GVHD but also the outcome of the transplant.

Besisik S., Budak T., Yenerel M. N., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , vol.23, 1999 (SCI-Expanded) identifier

188. The sexual relationship in hematopoietic stem cell transplantation survivers.

Atalan N., Kalayoglu-Besisik S., Sargin D.
BONE MARROW TRANSPLANTATION , vol.23, 1999 (SCI-Expanded) identifier

189. High risk of chronic graft-versus-host disease in unmanipulated allogeneic peripheral blood stem cell transplantation

Kalayoglu-Besisik S., Budak-Alpdogan T., Yenerel M. N., Sargin D., Tangun Y.
BLOOD , vol.92, no.8, pp.2973-2975, 1998 (SCI-Expanded) identifier identifier identifier

190. A new method for the detection of bcr/abl sequences amplified by Polymerase Chain Reaction (PCR) following bone marrow transplantation

Yazici H., KALAYOGLU S., DALAY N.
Research Communications in Molecular Pathology and Pharmacology , vol.101, no.3, pp.297-306, 1998 (SCI-Expanded) identifier identifier identifier

191. Thrombocytopenia in allogeneic peripheral blood stem cell transplantation (allo-PBSCT) donors.

Besisik S., Alpdogan T., Yenerel M. N., Altay S., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , vol.21, 1998 (SCI-Expanded) identifier

192. Allogeneic peripheral blood stem cell transplantation (allo-PBSCT) versus allogeneic bone marrow transplantation (allo-BMT): Rapid engraftment but increased morbidity due to GVHD

Besisik S., Yenerel M. N., Alpdogan T., Yavuz A., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , vol.21, 1998 (SCI-Expanded) identifier

193. The influence of flow cytometric (FC) gating strategy and cell preparation procedures on CD34+ cell enumeration.

Budak-Alpdogan T., Yenerel M. N., Besisik-Kalayoglu S., Yanasik M., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , vol.21, 1998 (SCI-Expanded) identifier

194. The value of reticulocyte maturity index (RMI) as a predictor of engraftment in allogeneic peripheral blood stem cell transplantation (allo-PBSCT)

Yenerel M. N., Besisik S., Alpdogan T., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , vol.21, 1998 (SCI-Expanded) identifier

195. Graft versus myeloma effect augmented by donor leukocyte infusions (DLI) following an incomplete response to allogeneic blood stem cell transplantation (ALLO-BSCT): A case report.

Besisik S., Yenerel M. N., Alpdogan T., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , vol.21, 1998 (SCI-Expanded) identifier

196. Cyclosporin-related reversible muscular toxicity [1]

Budak-Alpdogan T., Kalayoglu-Besisik S., Sargin D., Tangun Y.
Bone Marrow Transplantation , vol.22, no.1, pp.115-116, 1998 (SCI-Expanded) identifier identifier identifier

197. Evaluation of chimerism with DNA polymorphisms in bone marrow transplantation

Ozbek U., Vural B., Kalayoglu S., Soysal T., Bilgen H., Yavuz S., et al.
Turkish Journal of Pediatrics , vol.39, no.3, pp.303-311, 1997 (SCI-Expanded) identifier identifier identifier

198. Incidence and severity of GVHD in allogeneic peripheral blood stem cell transplantation (ALLO-PBSCT). Analysis of 21 patients.

Besisik S., Yenerel M. N., Alpdogan T., Sargin D., Tangun Y.
BLOOD , vol.90, no.10, pp.4495, 1997 (SCI-Expanded) identifier

199. The results of combination chemotherapy (vincristine, melphalan/doxorubicin, cyclophosphamide and prednisolone) (VMCP and VCAP) in multiple myeloma MULTIPL MIYELOM TEDAVISINDE VINCRISTIN, MELPHALAN/DOXORUBICIN, CYCLOPHOSPHAMIDE VE PREDNIZOLON KOMBINASYONUILE ELDE EDILEN TEDAVI SONUCLARININ DEGERLENDIRILMESI

Nalcaci M., Sargin D., Atamer T., Pekcelen Y., Tangun Y., Kalayoglu S.
Istanbul Tip Fakultesi Mecmuasi , vol.59, no.2, pp.12-15, 1996 (Scopus) identifier

200. The differential diagnosis of anemia and the mean corpuscular volume ANEMININ AYIRICI TANISI VE ORTALAMA ERITROSIT HACMI

Nalcaci M., Kalayoglu S., Sargin D., Atamer T., Pekcelen Y., Tangun Y.
Istanbul Tip Fakultesi Mecmuasi , vol.58, no.1, pp.74-77, 1995 (Scopus) identifier

201. Idiopathic thrombocytopenic purpura. The clinical, hematological findings and therapeutic results of 156 cases IDIOPATIK TROMBOSITOPENIK PURPURALI 156 HASTANIN KLINIK, LABORATUAR BULGULARI VE CESITLI TEDAVILERLE ELDE EDILEN SONUCLAR

Nalcaci M., Atamer T., Sargin D., Kalayoglu S., Pekcelen Y.
Istanbul Tip Fakultesi Mecmuasi , vol.57, no.3, pp.32-35, 1994 (Scopus) identifier

202. Intensive therapy for patients with acute lymphoblastic leukemia (preliminary results of BFM protocol)

Nalcaci M., Sargin D., Atamer T., Pekcelen Y., Tangun Y., Kalayoglu S.
Klinik Gelisim , vol.6, no.9, pp.2614-2617, 1993 (Scopus) identifier

203. Hematological complications of diphenylhydantoin therapy

Nalcaci M., Sargin D., Atamer T., Pekcelen Y., Tangun Y., Agan M., et al.
Klinik Gelisim , vol.6, no.6, pp.2510-2512, 1993 (Scopus) identifier

204. The place of L-thyroxine treatment in the prevention of recurrence following subtotal thyroidectomy performed for nontoxic goiter

Besisik F., Molvalilar S., Kalayoglu S., Tascioglu C., Gencer E., Acar A., et al.
Klinik Gelisim , vol.6, no.3, pp.2317-2320, 1993 (Scopus) identifier

205. Cushing's syndrome with pheochromocytoma

Kalayoglu S., Orhan Y., Ozarmagan S., Azezli A., Aral F., Dizdaroglu F., et al.
Istanbul Tip Fakultesi Mecmuasi , vol.55, no.1, pp.243-246, 1992 (SCI-Expanded) identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 206

1. Multipl Miyelom'da Genetik Karmaşa: Optik Genom Haritalamanın Yeri

BAYRAK TOKAÇ A. G., ERDEM S., ADAY A., MUTLU M. B., GÜNEY D. K., MASTANZADE M., et al.
12. Hematolojik Onkoloji Kongresi, KKTC, Turkey, 02 October 2025, pp.134-137, (Summary Text)

2. Kronik Lenfositik Lösemide Optik Genom Haritalamanın FISH Analizine Tamamlayıcı Rolü: Tek Merkez Pilot Çalışma

ERDEM S., BAYRAK TOKAÇ A. G., ADAY A., KARACA D., MUTLU M. B., ÇEFLE K., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 02 November 2025, pp.121-122, (Summary Text)

3. Yaygın Deri Nodülleri ile Nadir Bir Lenfoma: Subkutan Pannikülit Benzeri T-hücreli Lenfoma Seyrinden Alıntılar

KORUK K., BOZAN B., ERDEM S., GÜNGÖR ŞAHİN G., ALTAY A. Y., YEGEN G., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October 2025, pp.308, (Summary Text)

4. Bir Taşla İki Kuş: Akalabrutinib ile KLL ve Anjiyoödem Kontrolü

SARAÇ Z., ERDEM S., KORUK K., MASTANZADE M., HÖRMET İĞDE M., YEĞİT O. O., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October 2025, pp.337-338, (Summary Text)

5. Yeni Tanı Multipl Miyelomda Tromboz Riskinin Öngörülmesi: 589 Hastalık Gerçek Yaşam Deneyimi

MASTANZADE M., HASANZADE U., İNAN N. Y., TAHA F. J., EMEL P., ERDEM S., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October 2025, pp.191, (Summary Text)

6. Hemofagositik lenfohistiyositoz gelişen metilmalonik asidemi hastası: Nadir bir olgu sunumu

DOĞAN E. E., VARELCİ S., KARAKAYA N. R., AK B., MUTLU Ü., ERDEM S., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.32-33, (Summary Text)

7. Allopurinol ilişkili SDRIFE (simetrik, ilaç ilişkili, intertriginöz ve fleksural ekzantem): Anımsanması gereken bir deri tepkimesi

YILDIZ B., KILIÇ İ., ERDEM S., BEŞIŞIK S.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.50-51, (Summary Text)

8. Acil Dahiliye Kliniğine Trombotik Mikroanjiyopati Tanısı ile Başvuran Hastaların Tanısal Dağılımı: Tek Merkez Deneyimi

DENİZ D., GÜZEL DİRİM M., YILMAZ B., ERDEM S., ŞENKAL N., MEDETALİBEYOĞLU A., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.25-26, (Summary Text)

9. Asitle prezente olan periferik T hücreli lenfomalar, başka türlü sınıflandırılmayan (PTCL NOS) nüksü olgusu

MAHAMMADLİ F., HASANZADE U., ERDEM S., ALTAY A. Y., BEŞIŞIK S.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Turkey, 10 April 2025, pp.34, (Summary Text)

10. The Silent Threat of Secondary Malignancies in Multiple Myeloma Patients: A Cohort Study from Turkey in the Era of New Drugs

Mastanzade M., Taha F. J., Hasanzade U., İnan N. Y., Zeynallı B., Ören Çelik M. M., et al.
The 11th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy), Paris, France, 15 May 2025, (Summary Text)

11. REVERSIBLE DIFFUSE CHOROIDAL LEAKAGE ASSOCIATED WITH DARATUMUMAB AND SUCCESSFULLY MANAGED WITH CONTINUED DESENSITIZATION THERAPY

Mastanzade M., Cebeci Z., Koruk K., Yiğit K., Beşışık S.
The 11th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy), Paris, France, 16 May 2025, pp.1, (Summary Text)

12. Hemophagocytic lymphohistiocytosis syndrome (HLH) in HIV-infected patients with Kaposi sarcoma: the first case series from a single centre in Turkey

ORTA Z., ÇAĞATAY A. A., BENLİ A., BAŞARAN S., ERDEM S., BEŞIŞIK S.
35th Congress of the European Society of Clinical Microbiology and Infectious Diseases, Viyana, Austria, 11 April 2025, pp.4832, (Summary Text)

13. A Single-Center Real-Life Experience with First-Line Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (DARA-VCD) in AL Amyloidosis

MASTANZADE M., ÖREN ÇELİK M. M., ERDEM S., ÖZBALAK M. M., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Hematoloji Uzmanlık Derneği 18. Ulusal Kongresi, Antalya, Turkey, 21 - 24 November 2024, vol.46, pp.26-27, (Summary Text)

14. Erişkin yaşta tanı alan immün sistemin doğuştan kusurları hastalarının yönteiminde karşılaşılan problemler: Gerçek yaşamda zor vaka serisi

DEMİR S., ÜNAL D., TOPRAK İ. D., KORKMAZ P., KAHVECİ N., hörmet iğde M., et al.
XXX. Uluslararası Katılımlı Ulusal Allerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 27 November - 01 December 2024, (Summary Text)

15. Optical Genome Mapping in Newly Diagnosed Chronic Lymphocytic Leukemia

ERDEM S., BAYRAK TOKAÇ A. G., ADAY A., KARACA D., ÖZTÜRK Ş., ÇEFLE K., et al.
66th ASH Annual Meeting and Exposition, San Diego, CA, United States Of America, 7 - 10 December 2024, pp.6758, (Summary Text)

16. Does Human Leukocyte Antigens Heterozygosity Influence the Gut Microbiota?

Gürer E. E., Öğret Y., SEZERMAN O. U., Onat P., KIVANÇ D., AKTAŞ Z., et al.
Balkan EPT meeting 2024, İstanbul, Turkey, 15 November 2024, (Full Text)

17. Disseminated Gonococcal Infection In A Patient Receiving Eculimuzab Treatment

ŞEYMA K., AKGÜN KARAPINAR D. B., KORUK K., BEŞIŞIK S., ÖNGEN B.
XLI. Türk Mikrobiyoloji Kongresi, Turkey, 13 - 17 November 2024, (Summary Text)

18. Akut Miyeloid Lösemide İzositrat Dehidrogenaz 1 (IDH1) Gen Mutasyonu Sıklığı ve Klinik: Tek Merkez Deneyimi

ÇATMA Y., ERDEM S., ADAY A., MASTANZADE M., ÖZBALAK M. M., YÖNAL HİNDİLERDEN İ., et al.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.228, (Summary Text)

19. Kardiyak Amiloidozda Ani Ölümde İntrakardiyak Defibrilatör Etkisi: Olgu Sunumu

KORUK K., ERDEM S., BEŞIŞIK S., KARAAYVAZ E. B., ÇAKMAK A.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.294-295, (Summary Text)

20. AL Amiloidozda Karaciğer Tutulumunun Sessiz İzleri: Fibroscan Yol Gösterir mi?

MASTANZADE M., DAĞCI G., ÖREN ÇELİK M. M., ERDEM S., ÇAVUŞ B., SAKCI E., et al.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.185, (Summary Text)

21. Bağışıklığı Tam Hastada Eş Zamanlı Multipl Miyelom ve Kaposi Sarkomu

HASANZADE U., ÇATMA Y., ERDEM S., DENİZ D., KARAKAYA N. R., ALTAY A. Y., et al.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.302, (Summary Text)

22. Yeni Tanı Hodgkin Lenfoma Hastalarında Monosit Alt Tiplerinin Dağılımı ve Erken Tedavi Yanıtına Etkisi

AYDIN T., ELVERDİ T., SAĞLAM K., ERDEM S., ASA S., ÇAVUŞOĞLU M., et al.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.114-115, (Summary Text)

23. İleri Evre Mide Kanseri Tanılı Hipertiroid Hastanın Preoperatif Hazırlığında Plazmaferez ile Birlikte Rektal Metimazol Kullanımı

Güneş Ş., Hacişahinoğulları H., Yenidünya Yalın G., Gül N., Soyluk Selçukbiricik Ö., Beşışık S., et al.
Endokurs8, Şanlıurfa, Turkey, 31 October - 03 November 2024, pp.46-47, (Summary Text)

24. Systemic AA Amyloidosis as a Complication of Idiopathic Multicentric Castleman's Disease

USTA T., SAKCI E., ERDEM S., TEZCAN K., YEGEN G., BEŞIŞIK S.
11th SOHO Türkiye Meeting, İstanbul, Turkey, 28 April 2024, vol.24, pp.427-428, (Summary Text)

25. A Rare Case of Plasmablastic Lymphoma Presenting With a Bulky Renal Mass in an Immunocompetent Patient

SAKCI E., TAGHİYEVA N., USTA T., ERDEM S., İNAN N. Y., ALTAY A. Y., et al.
11th SOHO Türkiye Meeting, İstanbul, Turkey, 28 April 2024, vol.24, pp.467-468, (Summary Text)

26. Primary Hemophagocytic Lymphohistiocytosis in an Adult Woman: Griscelli Syndrome Type 2 (Gs2) Without Hypopigmentation

USTA T., TİRYAKİ T. O., SAKCI E., ERDEM S., BEŞIŞIK S.
11th SOHO Türkiye Meeting, İstanbul, Turkey, 28 - 30 April 2024, vol.24, pp.601, (Summary Text)

27. Ailesel Hiperkolesteroleminin Tedavisinde Düşük Yoğunluklu Lipoprotein Kolesterol Aferezinin Etkinliği; Tek Merkez Deneyim

HACİŞAHİNOĞULLARI H., BİLİK OYMAN G., MUTLU Ü., DADIN S., YENİDÜNYA YALIN G., SOYLUK SELÇUKBİRİCİK Ö., et al.
45. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Antalya, Turkey, 17 - 21 April 2024, pp.122-123, (Summary Text)

28. KAPOSİ SARKOMU OLAN HIV İLE İNFEKTE 4 HASTADA FATAL SEYREDEN HEMOFAGOSİTİK LENFOHİSTİYOSİTOZ SENDROMU (HLH) - NE KADAR FARKINDAYIZ?

Abdullayeva Z., Çağatay A. A., Benli A., Başaran S., Erdem S., Beşışık S., et al.
HİV/AIDS 2023, Antalya, Turkey, 7 - 10 December 2023, pp.93-94, (Summary Text) Creative Commons License Sustainable Development

29. YAŞ VE CİNSİYETİN T VE B LENFOSİT ALT GRUP DAĞILIMINA ETKİSİ

Turğut Kaynak F., Yanaşık M., Çınar S., Beşışık S., Deniz G., Gelmez M. Y.
26. Ulusal İmmünoloji Kongresi, Ankara, Turkey, 11 - 13 November 2023, pp.47, (Summary Text)

30. Multipl miyelomda kemik iliği fibrozisinin ekstramedüller hastalık ile ilişkisi

Konyaoğlu H., Altay A. Y., Işık E. G., Oluk B., Taghiyeva N., Sakcı E., et al.
25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.77-78, (Full Text) Sustainable Development

31. HLA heterozigotluğu bağırsak mikrobiyotasını etkiler mi?

Gürer E. E., Ögret Y., Sezerman O. U., Onat P., İzgi D., Aktaş Z., et al.
18. TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, Ankara, Turkey, 26 - 29 October 2023, pp.15-16, (Summary Text)

32. PP 19 LOCALIZED AL AMYLOIDOSIS OF THE URINARY BLADDER PRESENTING WITH PAINLESS MASSIVE HEMATURIA Kıvanc Koruk ¸ 1 , Murat Ozbalak € 2 , Ali Altay 3 , Gul € cin Ye ¸ gen 3 , Sevgi Bes¸ ıs¸ ık Kalayoglu 1

Beşışık S.
XIV. Eurasian Hematology Oncology Congress, İstanbul, Turkey, 11 - 14 October 2023, pp.36, (Summary Text)

33. PP 14 INFECTION RATES ACROSS THE AUTOLOGOUS STEM CELL TRANSPLANTATION WITH REFLECTION OF MULTIPLE MYELOMA INDUCTION STORY IN TURKEY Shirkhan Amikishiyev 1 , Sevgi Kalayoglu Besisik 2 , Ipek Yonal Hindilerden 2 , Mustafa Nuri Yenerel 2 , Arif Atahan Cagatay 3 , Simge Erdem 2 , Gulkan Ozkan 4 , Meliha Nalcaci 2 , Deniz Sargin2

Beşışık S.
XIV. Eurasian Hematology Oncology Congress, İstanbul, Turkey, 11 - 14 October 2023, pp.37, (Summary Text)

34. PP 13 SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION AS CENTRAL NERVOUS SYSTEM LYMPHOMA RELAPSE SIGN OF NODAL DIFFUSE LARGE BCELL LYMPHOMA Nur Seda Ibili Cetinkaya ¸ 1 , Ulviya Hasanzade 1 , Gul € sah Alagoglu 2 , Nur Rana Karakaya 2 , Nigar Agzada 2 , Mehmet Baburo glu 3 , Sevgi Besisik

Beşışık S.
XIV. Eurasian Hematology Oncology Congress, İstanbul, Turkey, 11 - 14 October 2023, pp.37, (Summary Text)

35. PP 11 CUTANEOUS RICHTER TRANSFORMATION IN THE 16TH YEAR OF FOLLICULAR LYMPHOMA DIAGNOSIS Ulviyya Hasanzade 1 , Yunus Catma 1 , Nur Seda Ibılı Cetınkaya 1 , Beyza Oluk 1 , Simge Erdem 1 , Cem Hacıalıoglu 1 , Ahmet Oguz Celık 2 , Musa Falay 2 , Sevgi Kalayoglu Besısık

Beşışık S.
XIV. Eurasian hematology Oncology Congress, İstanbul, Turkey, 11 - 14 October 2023, pp.36

36. Cardiac AL amyloidosis experienced in the last decade from a single center

ERDEM S., MASTANZADE M., KARACA ÖZER P., ÇETİN O., HACIALİOĞLU A. C., AYDOĞAN M., et al.
20th International Myeloma Society Annual Meeting, Atina, Greece, 27 - 30 September 2023, vol.23, pp.275, (Full Text) identifier

37. CARDIAC AL AMYLOIDOSIS EXPERIENCED IN THE LAST DECADE FROM A SINGLE CENTER

Beşışık S.
IMS 20th Annual Meeting and Exhibition, Athens, Greece, 27 - 30 September 2023, pp.425, (Full Text)

38. NASOPHARYNGEAL PLASMACYTOMA WİTH TUMEFACTİVE AMYLOİDOSİS ("AMYLOİDOMA") PRESENTİNG WITH UNİLATERAL HEARİNG LOSS

Beşışık S.
IMS 20th Annual Meeting and Exhibition, Athens, Greece, 27 - 30 September 2023, pp.432, (Full Text)

39. THE GUT MICROBIOTA CHANGES DURİNG MULTIPLE MYELOMA TREATMENT

Beşışık S., Savra Oguz F., Aktaş Z., Öncül M. O., Gürer E. E., Tiryaki T. O., et al.
IMS 20TH Annual Meeting and Exhibition , Athens, Greece, 27 - 30 September 2023, vol.23, pp.258-259, (Full Text) Creative Commons License

40. TCL-223 Clonal CD4+ Cytotoxic T Lymphocytosis Concomitant With POEMS Syndrome: A Co-Existence of Key Findings for Relevance in the Pathogenesis

GULTEKIN B., KAYA B., GÖKSOY SOLAK Y., ALTINKAYNAK M., ÖNEÇ B., ALTAY A. Y., et al.
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting, Texas, United States Of America, 06 September 2023, vol.23, pp.467-468, (Full Text)

41. The relationship of bone marrow fibrosis with extramedullary disease in multiple myeloma

Konyaoğlu H., Altay A. Y., Işık E. G., Oluk B., Taghiyeva N., Sakcı E., et al.
28th Congress of the European Hematology Association (EHA 2023), Frankfurt, Germany, 08 June 2023, pp.1776, (Summary Text)

42. The role of 18F-FDG PET/CT Scan in adult langerhans cell histiocytosis: A single center experience

ERDEM S., ÇETİN O., KIRAN M. Y., IŞIK E. G., BEYAZ BELKAYA Ş., YEGEN G., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 5 - 07 May 2023, pp.40-41, (Summary Text)

43. Insight into hypereosinophilia from the hematology clinic; A single-center experience

OLUK B., TAGHİYEVA N., SAKCI E., ERDEM S., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.64, (Summary Text)

44. A different point of view: Facial paralysis as a manifestational of AL amyloidosis

KORUK K., FİDAN F., ASLANLI A., ERDEM S., BEŞIŞIK S.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.65, (Summary Text)

45. A rare case of multiple myeloma presenting as a cranial nerve palsy

SAKCI E., YÖNAL HİNDİLERDEN İ., TİRYAKİ T. O., OLUK B., ÇATMA Y., ERDEM S., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.61, (Summary Text)

46. IMPACT OF EPITOPE MATCH ON STEM CELL TRANSPLANTATION

Öğret Y., Tiryaki T. O., Nasr Zanjani B., İzgi D., Çınar Ç., Yönal Hindilerden İ., et al.
Society of hematologic oncology, İstanbul, Turkey, 5 - 07 May 2023, pp.33, (Summary Text)

47. CXCL12 CHEMOKINE AND RELATIONSHIP WITH MULTIPLE MYELOM

Gürer E. E., Şentürk Çiftçi H., Oğuz S. R., İzgi D., Beşışık S.
Society of hematologic oncology, İstanbul, Turkey, 5 - 07 May 2023, pp.26, (Summary Text)

48. Edinsel saf eritroit dizi aplazi tedavisi seyrinde Hodgkin Dışı Lenfoma: De novo? İmmunsupresif tedavi ilişkili?

KAYIKÇI K., KORUK K., ERDEM S., OLUK B., YEGEN G., ALTAY A. Y., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2023, Sapanca, Turkey, 09 March 2023, pp.29-30, (Summary Text)

49. Kan ürünleri transfüzyonları sorunlar ve çözümler

ERDEM S., BEŞIŞIK S.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2023, Sapanca, Turkey, 09 March 2023, pp.9-11, (Summary Text)

50. SENKRON İNTERSTİSYEL AKCİĞER HASTALIĞI, KARACİĞER SİROZU VE HİPOSELLÜLER KEMİK İLİĞİ: TELOMEROPATİLERE BİR İPUCU

ZARALI S., ALTINKAYNAK M., AKPINAR T. S., GÖKSOY SOLAK Y., ERTEN S. N., SAKA B., et al.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.170, (Full Text)

51. NADİR BİR İSKEMİK İNME NEDENİ: TROMBOTİK TROMBOSİTOPENİK PURPURA

Buğdaycı Z. G., Oluk B., Sezgin M., Erdem S., Ekizoğlu Turgut E., Beşışık S., et al.
58. ULUSAL NÖROLOJİ KONGRESİ , Antalya, Turkey, 19 - 24 November 2022, pp.326, (Summary Text)

52. Kitlesel lezyonlarla langerhans hücreli histiyositoz zeminininde gelişen langerhans hücreli sarkom

ERDEM S., SAKCI E., YAZKAÇ C., YEGEN G., BEŞIŞIK S.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.323-324, (Summary Text)

53. Bacak ve implant olmadan meme tutulumuyla prezente olan sistemik ALK pozitif anaplastik büyük hücreli lenfoma

SAKCI E., ERDEM S., ANDAÇ B., BEŞIŞIK S.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.321-322, (Summary Text)

54. Multipl miyelom dışı plazma hücre hastalıklarında kök hücre desteği ile yüksek doz kemoterapi deneyimi

TİRYAKİ T. O., YÖNAL HİNDİLERDEN İ., ERDEM S., MASTANZADE M., ÖZBALAK M. M., OLUK B., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.196-197, (Summary Text)

55. Büyük granüllü lenfosit artışı olan olguların tanısında immünfenotiplemenin rolü: Tek merkez deneyimi

NAZLIGÜL SERT E., TİRYAKİ T. O., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., ERDEM S., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.199-200, (Summary Text)

56. Burkitt lenfomanın 10 yıllık remisyonundan sonra plazmablastik lenfoma tanısı alan nadir bir olgu ve başarılı yönetimi

ERDEM S., SAKCI E., ANDAÇ B., KEBUDİ R., YEGEN G., BEŞIŞIK S.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.342-343, (Summary Text)

57. Kronik lenfositer lösemi olgularının tanı sırasındaki T lenfosit alt gruplarının prognoz üzerine etkisi

SEYİTHANOĞLU D., NAZLIGÜL SERT E., ERDEM S., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.145-146, (Summary Text)

58. SARS-COV-2 aşılama sonrası gelişen inme atakları ile tanı konulmuş immün trombotik trombositopenik purpura: Olgu sunumu

OLUK B., ERDEM S., TAGHİYEVA N., KIRKOĞLU A. M., BEŞIŞIK S.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.327, (Summary Text)

59. The Effect Of Age And Gender Differences On The Distribution Of T And B Lymphocyte Subsets

Turğut Kaynak F., Yanaşık M., Çınar S., Beşışık S., Deniz G., Gelmez M. Y.
5th International Molecular Immunology & Immunogenetics Congress, İzmir, Turkey, 20 - 22 October 2022, pp.55, (Summary Text)

60. Rare indications of Mepolizumab in eosinophilic disorders: A real-life study

DEMİR S., ÜNAL D., ÖZTOP UZ N., YEĞİT O. O., KARABACAK EYİCE D., KARADAĞ P., et al.
World Allergy Congress 2022 İstanbul, İstanbul, Turkey, 13 October 2022, pp.164, (Summary Text)

61. Treatment of a patient diagnosed with Erdheim Chester’s Disease in cooperation with plastic surgery and hematology

ERDEM S., ÖZLÜK D. Ö., KOZANOĞLU E., BEŞIŞIK S.
XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.19, (Summary Text)

62. A rare presentation of systemic AL amyloidosis; Pulmonary AL amyloidosis

ERDEM S., TAGHİYEVA N., AKIN K., KONYAOĞLU H., BEŞIŞIK S.
XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.19, (Summary Text)

63. An unusual ocular lymphoma, primary intravitreal lymphoma diagnosed incidentally

İBİLİ ÇETİNKAYA N. S., ERDEM S., DENİZ N., BAŞARIR B., ARTUNAY H. Ö., TİRYAKİ T. O., et al.
XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.30-31, (Summary Text)

64. Glomerular microangiopathy with marked systemic thrombotic microangiopathy shortly after bortezomib in a newly diagnosed POEMS syndrome patient

Tiryaki T. O., Işık A., Erdem S., Güller N., Kemeç G., Yazıcı H., et al.
XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.38, (Summary Text)

65. Inhibition Complement C5 Improves Severe Hemolytic Anemia in Cold Agglutinin Disease With – No Response to Glucocorticoids and Rituximab

ERDEM S., ÇATMA Y., BEŞIŞIK S.
17th WORLD APHERESIS ASSOCIATION CONGRESS, İstanbul, Turkey, 14 September 2022, (Summary Text)

66. TTP Activation During COVID19 Infection; A triggering or a consequence reaction?

TİRYAKİ T. O., ÖZLÜK D. Ö., ERDEM S., ALTAY DADIN S., BEŞIŞIK S.
17th World Apheresis Association Congress, İstanbul, Turkey, 14 September 2022, (Summary Text)

67. Karaciğer Amiloidoz Depolanmasını Göstermede Yeni Bir Non-İnvazif Tanı Yöntemi Olarak Transient Elastografi (Fibroscan)

BEKTAŞ M., ÇAVUŞ B., AĞARGÜN B. F., ŞENKAL V., KOCA N., İNCE B., et al.
ROMATOLOJİDE HEDEF 2022 SEMPOZYUMU, İstanbul, Turkey, 9 - 11 June 2022, pp.34-35, (Summary Text)

68. Red cell alloimmunization in multi-transfused Turkish patients with hematologic disorders

Öztaşkın S., Yanaşık M., Özbalak M. M., Güzel Mastanzade M., Özlük Ö., Tiryaki T. O., et al.
EHA 2022 Hybrid Congress, Vienna, Austria, 9 - 17 June 2022, pp.2844, (Summary Text)

69. POTENTIAL PREDICTORS OF OUTCOME FOR ANAKINRA TREATMENT IN COVID-19 PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME

AMIKISHIYEV S., Deniz R., GÜNVER M. G., Aghamuradov S., Koca N., İNCE B., et al.
Annual European Congress of Rheumatology (EULAR), Copenhagen, Denmark, 1 - 04 June 2022, no.73, pp.937-938, (Summary Text) Creative Commons License Sustainable Development identifier

70. Epitop Uyumsuzluklarının Hematopoetik Kök Hücre Nakli Üzerine Etkisi

Ögret Y., Tiryaki T. O., Zanjani B. N., Kıvanç D., Çınar Ç., Yönal Hindilerden İ., et al.
8. Ulusal Transplantasyon İmmunolojisi ve Genetiği Kongresi, Antalya, Turkey, 14 - 17 April 2022, pp.88-89, (Summary Text)

71. Allogeneik Kök Hücre Nakli Hastalarında Erken Evre Doku Kimerizminin Periferik Kan Kimerizmi İle İlişkisi

Ögret Y., Pınar Özbalak E., Yönal Hindilerden İ., Beşışık S., Nalçacı M., Oğuz F.
8. Ulusal Transplantasyon İmmunolojisi ve Genetiği Kongresi, Antalya, Turkey, 14 - 17 April 2022, pp.31-32, (Summary Text)

72. Epitop Uyumsuzluklarının Hematopoetik Kök Hücre Nakli Üzerine Etkisi

Duvarcı Öğret Y., Tiryaki T. O., Nasr Zanjanı B., Kıvanç D., Çınar Ç., Yönal Hindilerden İ., et al.
8. ULUSAL TRANSPLANTASYON İMMÜNOLOJİSİ VE GENETİĞİ KONGRESİ, Antalya, Turkey, 14 - 17 April 2022, pp.88, (Summary Text)

73. HYPERGAMMAGLOBULINEMIA AND ALVEOLAR HEMORRHAGE IN THE COURSE OF INDOLENT LYMPHOMA IN A PATIENT PRESENTING WITH A GIANT HEPATIC MASS

Bektaş E., Yılmaz A., Tiryaki T. O., Gülseren Ü. A., Göksoy Solak Y., Akpınar T. S., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2022, Sakarya, Turkey, 24 - 27 March 2022, pp.37-38, (Full Text)

74. Examination of CXCL12 Expression Regulation and Association with Multiple Myeloma and Other Diseases

Gürer E. E., Şentürk Çiftçi H., Kıvanç D., Beşışık S., Oğuz F.
VIII. INTERNATIONAL CONGRESS OF MOLECULAR MEDICINE, 9 - 12 December 2021, pp.2, (Summary Text)

75. Relationship between HLA and COVID-19 in unrelated bone marrow donors

Erol A., D. Öğret Y., Kıvanç D., Süleymanoğlu M., Özbalak M. M., Beşışık B., et al.
Hacettepe Acta Medica- XVII. Congress of Medical Biology and Genetics, 28 - 31 October 2021, vol.52, pp.407-408, (Summary Text) Creative Commons License

76. Tirotoksikoz Gelişen İkiz Eşi Molar Gebelikte Plazmaferez Tedavisi İle Cerrahi Hazırlık

Telci Çaklılı Ö., Demirkol N., Nasifova V., Ateş Tıkız M., Aksoy Gökkaya Ö., Soyluk Selçukbiricik Ö., et al.
9.Tiroid Hastalıkları Kongresi, Türkiye, 01 Aralık 2021, 1 - 04 December 2021, pp.22, (Summary Text) Creative Commons License

77. AN UNUSUAL SURVIVING HISTORY: MULTISYSTEM INVOLVEMENT UNTIL ADULT LIFE WITH NIEMANN PICK TYPE B

Kubilay D. Ö., Mastanzade M., Oluk B., Beşışık S., Ballyyev B.
XIIth Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 10 - 13 November 2021, pp.20, (Summary Text)

78. ASPARAGINASE INDUCED SINUS VEIN THROMBOSIS IN AN ADULT YOUNG ALL PATIENT

OLUK B., KUBİLAY D. Ö., ÖZBALAK M. M., ERDEM S., BEŞIŞIK S.
XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.77, (Summary Text)

79. WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

ERDEM S., MASTANZADE M., ÖZBALAK M. M., KUBİLAY D. Ö., TİRYAKİ T. O., OLUK B., et al.
XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.96, (Summary Text)

80.

Doğan E. E., Mutlu Ü., Hacişahinoğulları H., Gürşahbaz O. C., Üçok V. A., Soyluk Selçukbiricik Ö., et al.
Endokurs 5, Antalya, Turkey, 10 - 14 November 2021, pp.148, (Summary Text) Creative Commons License Sustainable Development

81. ASPARAGINASE INDUCED SINUS VEIN THROMBOSIS IN AN ADULT YOUNG ALL PATIENT

Oluk B., Beşışık S.
XIIth Eurasian Hematology Oncology Congress, İstanbul, Turkey, 10 - 13 November 2021, pp.1, (Summary Text)

82. A CASE OF MULTI REGIONAL PRIMARY MUSCLE LYMPHOMA

Oluk B., Mastanzade M., Ibili N. S., Beşışık S.
XIIth Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 10 - 13 November 2021, pp.41, (Summary Text)

83. Yeni tanı DBBHL’de biyobenzer rituksimab (Redditux) içeren R-CHOP rejimi sonuçları: Tek merkez gerçek yaşam deneyimi

ÖZBALAK M. M., MASTANZADE M., KUBİLAY D. Ö., TİRYAKİ T. O., ERDEM S., Pınar Özbalak E., et al.
47. Ulusal Hematoloji Kongresi, Antalya, Turkey, 04 November 2021, (Full Text)

84. A Refractory Thrombotic Thrombocytopenic Purpura Case Complicated by Hepatic Sinusoidal Obstruction Syndrome and Successful Management with Defibrotide

Erdem S., Mastanzade M., Altay Dadın S., Yanaşık M., Beşışık S.
ISTH 2021 Congress, Pennsylvania, United States Of America, 17 - 21 July 2021, no.5, pp.630-631, (Summary Text)

85. A Case of Congenital Afibrinogenemia with Two Successful Spontaneous Delivery after Recurrent Pregnancy Losses

Mastanzade M., Özbalak M. M., Beşışık S.
ISTH 2021 Congress, Pennsylvania, United States Of America, 17 - 21 July 2021, no.5, pp.312, (Summary Text)

86. Preliminary Criteria for Macrophage Activation SyndromeAssociated with Coronavirus Disease-19

Amikishiyev S., Günver M. G., Bektaş M., Aghamuradov S., İnce B., Koca N., et al.
American College of Rheumatology 2021, Arizona, United States Of America, 5 - 09 November 2021, vol.10, no.73, pp.1-4, (Summary Text) Creative Commons License Sustainable Development

87. Transient Elastography (fi broscan); As a New Non-invasiveDiagnostic Method for Detecting Hepatic Involvement ofAmyloidosis

Bektaş M., Çavuş B., Ağargün B. F., Şenkal İ. V., Koca N., İnce B., et al.
ACR, Arizona, United States Of America, 5 - 09 November 2021, vol.10, no.73, pp.1-4, (Summary Text) Creative Commons License

88. HLA allele and haplotype frequencies in a subset of 456 Turkish patients in the blood and bone marrow donor registry of Istanbul Medical Faculty

Oğuz F., Duvarcı Öğret Y., Erol A., Çınar Ç., Kıvanç D., Şentürk Çiftçi H., et al.
6th European Congress of Immunology , 1 - 04 September 2021, pp.294, (Summary Text) identifier identifier

89. A Comparison of Plasmapheresis Methods in the Treatment of Late Antibody Mediated Rejection

ÇALIŞKAN Y. K., YAZICI H., DİRİM A. B., AKSOY E., ŞAFAK S., Güller N., et al.
American Transplant Congress 2021, United States Of America, 4 - 09 June 2021, vol.21, pp.451, (Summary Text)

90. PRELIMINARY CRITERIA FOR MACROPHAGE ACTIVATION SYNDROME ASSOCIATED WITH CORONAVIRUS DISEASE-19

AMIKISHIYEV S., Gunver M. G., BEKTAŞ M., AGHAMURADOV S., İNCE B., KOCA N., et al.
European Congress of Rheumatology, ELECTR NETWORK, 01 January 2021, vol.80, pp.191-192, (Summary Text) Creative Commons License Sustainable Development identifier

91. Microbiota Analysis After Allogeneic Stem Cell Transplantation in Blood Diseases

Oğuz F., Gürer E. E., Aktaş Z., Beşışık S., Öncül M. O.
Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi, İstanbul, Turkey, 26 - 30 May 2021, pp.1-3, (Summary Text)

92. Blood and bone marrow donor regıstry of ıstanbul medıcal faculty actıvıty ın past 3 years.

Oğuz F., Erol A., Çınar Ç., Kıvanç D., Süleymanoğlu M., Şentürk Çiftçi H., et al.
HLA Dergisi, 34th European Immunogenetics and Histocompatibility Conference, 21 - 23 April 2021, pp.330, (Summary Text)

93. Erişkin kişide çene kemiğinde litik lezyon; diş hekimliğinden iç hastalıklarına multidisipliner yaklaşım

BEŞIŞIK TERZİOĞLU B. M., ÖZLÜK D. Ö., OLUK B., ERDEM S., BEKTAŞ KAYHAN K., İPEK G., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2021, Online, Turkey, 11 March 2021, pp.35, (Summary Text)

94. CASTLEMAN HASTALIĞI’NIN NADIR BIR FORMU: TAFRO SENDROMU

Ük E., DİRİM A. B., MEDETALİBEYOĞLU A., AKIN A., ŞENKAL N., ERDEM S., et al.
Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme, İstanbul, Turkey, 11 March 2021, (Summary Text)

95. EFFECT OF MICROBIOTA IN ALLOGENIC HEMATOPOETIC STEM CELL TRANSPLANTATION: ENGRAFTMENT AND GVHD

Oğuz F., Gürer E. E., Beşışık S., Aktaş Z., Öncül M. O.
Mikrobiyoloji Sempozyumu, İstanbul, Turkey, 25 - 27 December 2020, pp.155-157, (Full Text)

96. COVID-19 hastalarında Antitrombin-III seviyelerinin prognostik önemi

Anaklı İ., Ergin Özcan P., Polat Ö., Orhun G., Alay G., Tuna V., et al.
20. Ulusal Yoğun Bakım E- Kongresi (uluslararası katılımı) , İstanbul, Turkey, 10 - 15 November 2020, pp.1, (Summary Text) Sustainable Development

97. BAŞVURU ANI TAM KAN SAYIMI PUANLAMASININ COVID-19 HASTALARINDA İLERLEYİCİ HASTALIĞI GÖSTERMEDE ROLÜ

ÖZBALAK M. M., BEŞIŞIK S., TOR Y. B., MEDETALİBEYOĞLU A., KÖSE M., Şenkal N., et al.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, (Summary Text)

98. Prognostic value of pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratio in diffuse large B-cell lymphoma: a single-center experience

Dağcı G., Mastanzade M., Özbalak M. M., Kubilay D. Ö., Tiryaki T. O., Yönal Hindilerden İ., et al.
XIth Eurasian Hematology Oncology Congress, İstanbul, Turkey, 21 - 24 October 2020, no.42, pp.48-49, (Summary Text)

99. Experience of istanbul faculty of medicine bone marrow bank: periodical activity documentation

Oğuz F., Erol A., Süleymanoğlu M., Çınar Ç., Şentürk Çiftçi H., Beşışık S.
XIth Eurasian Hematology Oncology. EHOC Vırtual, İstanbul, Turkey, 21 - 24 October 2020, pp.65, (Summary Text) Creative Commons License

100. FUSARİUM SPP İLE SİNOPULMONER İNFEKSİYON: HEMATOLOJİK MALİGNİTELERDE İKİNCİ SIKLIKTA KÜF MANTARI İNFEKSİYONU

ÖZLÜK SEVEN Ö., OLUK B., ÖZBALAK M. M., SOLTANOVA L., ALTUNOK D., YILMAZ E., et al.
46. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 28 - 31 October 2020, pp.177-178, (Full Text)

101. Dipyridamole Added to Anticoagulant Prophylaxis: Decline in Poor Outcome of Clinically Severe Ill COVID-2019 Patients

BEŞIŞIK S., ÖZBALAK M. M., TOR Y. B., MEDETALİBEYOĞLU A., KÖSE M., Şenkal N., et al.
International Society on Thrombosis and Hemostasis Annual Congress 2020, 12 - 14 July 2020, (Summary Text)

102. A challenging disease: Congenital plasminogen deficiency

ÜNÜVAR A., KARAMAN S., KARAKAŞ Z., BİLİCİ M., ÇUKUROVA F., ALTINKURT E., et al.
HAEMOPHILIA, 14 - 19 June 2020, vol.26, pp.69-70, (Summary Text)

103. ERİŞKİN YAŞ LİZİNÜRİK PROTEİN İNTOLERANSI HASTASINDA KEMİK İLİĞİ TUTULUMU SONRASI GELİŞEN HEMOFAGOSİTİK SENDROM

Gülseren Ü. A., DENİZ R., ALTINKAYNAK M., BEŞIŞIK S., ERTEN S. N., TAŞCIOĞLU C.
21. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 9 - 13 October 2019, pp.313, (Full Text)

104. LANGERHANS HÜCRELİ HİSTİYOSİTOZ: TEK MERKEZ DENEYİMİ

DEMİR N., TURAN ERKEK E., ERDEM S., NALÇACI M., BEŞIŞIK S.
45. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2019, pp.155-156, (Summary Text)

105. Role of [68Ga]-pentixafor-PET/CT as a novel imaging of cxcr4 expression in multiple myeloma comparison to [18F]-FDG-PET/CT

TİRYAKİ T. O., KUYUMCU S., HAS ŞİMŞEK D., ÖZBALAK M. M., KUBİLAY D. Ö., ÜNAL S. N., et al.
Xth International Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 8 - 12 October 2019, vol.85, (Summary Text)

106. The efficacy of reuse therapeutic plasma exchange in relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a single-center experience of 130 cases

Mastanzade M., Besisik S., Dadin S. A., Aktan M., Hindilerden I. Y., Yenerel M. N., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

107. A regional hemovigilance study of transfusion-related adverse events at a university hospital from Istanbul

Kaftancioglu U., Atesmen C., Yanik N., Yanasik M., Kalayoglu S.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85 identifier

108. Adult-onset ligneous gingivitis associated with plasma cell dyscrasia in the absence of plasminogen deficiency

Aksoy E., Mastanzade M., Kalayoglu-Besisik S.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

109. A retrospective analysis of peripheral T-cell lymphoma patients: single-center 'real-life' experience

Ozbalak M. M., Besisik S., Mastanzade M., Ozluk O., Ozmen A., Hindilerden I. Y., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

110. A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment

Erdem S., Ozbalak M. M., Baykal C., Besisik S.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

111. Recombination frequencies in HLA loci among Turkish patients with hematological malignancies and their family-based donors

Cinar Ç., Karahan G., Kaya G., Kalayoglu-Besisik S., Oguz F.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

112. Clinical relevance of minor histocompatibility antigens

Oguz F., Cinar Ç., Oguz S., Sargin D., Besisik S.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

113. Red blood cell alloantibodies in thalassemia major patients: an analysis from Istanbul

Yanasik M., Besisik S., Karaman S., Tugcu D., Karakas Z.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

114. Late renal aspergilloma after autologous stem cell transplantion mimicking secondary malignancy

Altinkaynak M., Besisik S., Tascioglu C.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

115. Association of human leukocyte antigen groups with oral mucositis in patients undergoing bone marrow transplantation

Tufan A., Oguz F., Tufan F., Kekik Ç., Tarakci F. B., Sargin D., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

116. Long-time overlooked blastic plasmacytoid dendritic cell neoplasm evolving into multiple organ involvement presentation

Istemihan Z., Ozkan S., Dogan O., Yonal-Hindilerden I., Kalayoglu-Besisik S.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier identifier

117. Role of [Ga-68]-pentixafor-PET/CT as a novel imaging of cxcr4 expression in multiple myeloma; comparison to [F-18]-FDG-PET/CT

Tiryaki T. O., Kuyumcu S., Has-Simsek D., Ozbalak M. M., Ozluk D., Unal S., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

118. Serological weak d phenotypes and RHD genotype frequency among Turkish blood donors

Yanasik M., Besisik S., Ozturk G., Huslu M., Temurhan S., Usta S. A., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text) identifier

119. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic transplantation: Retrospective multicenter study of Turkish hematology research and education group (THREG), updated data

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.254-255 identifier

120. Comparison of outcomes of total body irradiation (TBI) vs non-TBI conditioning regimens in acute lymphoblastic leukemia for allogeneic transplantation

Bekoz H. S., Sevindik O. G., Ozcelik T., Arat M., Hindilerden I. Y., Besisik S., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.217-218, (Summary Text) identifier

121. Ga-68-Pentixafor PET: Hematolojik Malignitelerde Kemokin-4 Reseptör Hedefli Yaklaşım ve F-18-FDG PET ileKarşılaştırılması

ENGİN M. N., HAS ŞİMŞEK D., ŞANLI Y., BEŞIŞIK S., KUYUMCU S.
31. ULUSAL NÜKLEER TIP KONGRESi, Turkey, 10 - 14 April 2019, vol.1, pp.3, (Summary Text)

122. F-18 FDG-PET/CT Findings for Staging and Therapy Response Assessment of a Rare Case: Primary Uterine Cervical Lymphoma

ENGİN M. N., HAS ŞİMŞEK D., BEŞIŞIK S., ADALET I., MUDUN A., ÜNAL S. N.
8th BALKAN CONGRESS OF NUCLEAR MEDICINE, 10 - 14 April 2019, vol.1, pp.46, (Summary Text)

123. Secondary primary malignancies after autologous hematopoietic stem cell transplantation: Single center experience

TEKİN D., DAĞCI G., YÖNAL HİNDİLERDEN İ., ERDEM S., AKTAN M., NALÇACI M., et al.
44th Annual Meeting of the European Society for Blood and Marrow Transplantation, Lisbon, Portugal, 18 March 2018, (Summary Text)

124. Akut Lenfoblastik Lösemi’de Hazırlama Rejimine Tüm Vücut Işınlaması Eklenmesinin Nakil İlişkili Sonlanımlara Etkisi

BEKÖZ H. S., SEVİNDİK Ö. G., ÖZÇELİK E. T., ARAT M., YÖNAL HİNDİLERDEN İ., BEŞIŞIK S., et al.
44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October 2018, (Full Text)

125. Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

Yanaşık M., Erdem S., Mastanzade M., Uludağ Ö., Huslu M., Yüksel Kaftancıoğlu Ü., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, no.1, pp.68, (Summary Text)

126. Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

Yanaşık M., Erdem S., Mastanzade M., Beşışık S., Huslu M., Yüksel Kaftancıoğlu Ü., et al.
IXth International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, no.1, pp.68, (Summary Text)

127. Investigation of B-lymphocyte F-actin cell skeleton in multiple myeloma patients

Kilic E., Yalman N., Besisik S., Bektas M., Albeniz I.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) identifier

128. Concurrent myelomatous pleural effusion and extramedullary mediastinal involvement as relapse manifestation of multiple myeloma

Namazova N., Celik D., Erdogdu E., Kara M., Tascioglu C., Besisik S.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, (Summary Text) identifier

129. Evaluation of B and T cell chimerism after allogeneic stem cell transplantation in hematologic malignancies

Mastanzade M., Hindilerden I., Abatay F., Ogret Y., Savran F., Besisik S.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) identifier

130. Relationship between peripheral blood and tissue chimerisms in patients with allogeneic peripheral stem cell transplantation: preliminary results

Ozbalak E. P., Ogret Y., Mastanzade M., Oguz F., Besisik S.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) identifier

131. Chimerism by lineage-specific analysis in the course of clinical outcome

Ogret Y., Oguz F., Aktan M., Hindilerden I., Nalcaci M., Besisik S.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) identifier

132. qRT-PCR and STR-PCR chimerism method using after allogeneic hematopoietic stem cell transplantation

Sel F. A., Hindilerden I. Y., Mastanzade M., Ogret Y., Besisik S., Oguz F.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) identifier

133. Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient

Erdem S., Yanasik M., Mestanzade M., Uludag O., Huslu M., Kaftancioglu U. Y., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) identifier

134. Cancer-associated thrombotic microangiopathies for refractory thrombotic thrombocytopenic purpura differential diagnosis

Feriz S. N., Istemihan Z., Dadin S. A., Marangoz N., Ozdemir A., Tukek T., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text) identifier

135. Infectious epidemiology in Multiple Myeloma patients after Autologous Stem Cell Transplantation: A single-center analysis from Turkey

Amikishiyev S., Hindilerden I. Y., Erdem S., Aktan M., Nalcaci M., Sargin D., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.566-567, (Summary Text) identifier

136. Secondary primary malignancies after autologuous hematopoietic stem cell transplantation: Single center experience

Tekin D., Dagci G., Hindilerden I. Y., Erdem S., Aktan M., Nalcaci M., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.368-369, (Summary Text) identifier

137. Allojenik kemik İliği Nakli Yapılan Hastalarda Glutatyon S transferaz ve Sitokrom P450 Enzim Gen Polimorfizminin Klink Seyirle İlişkisi

Beşışık S., Yönal Hindilerden İ., Dağcı G., Nalçacı M., Bozbey H. U., Tekin D., et al.
V. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Malatya, Turkey, 27 - 29 April 2018, pp.1-3, (Summary Text) Creative Commons License

138. Multicenter Early Access Program Results from Turkey: Efficacy and Safety of Daratumumab Among Heavily Pretreated Relapse/Refractory Multiple Myeloma Patients

Beksac M., Aydin Y., Goker H., Turgut M., Besisik S., Cagirgan S., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130 identifier

139. RNA sequencing and in silico analysis of Myeloma cells in multiple myeloma patients

Sarıman M., SIRMA EKMEKCİ S., ABACI N., ÇAKİRİS A., PAÇAL F., ÜSTEK D., et al.
XV.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Fethiye- Muğla, Turkey, 26 - 29 October 2017, pp.108, (Summary Text)

140. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of Turkish Hematology Research and Education Group (ThREG)

Soyer N., Gunduz M., Tekgunduz E., ŞAHİN H. H., Yildizhan E., Okay M., et al.
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, France, 26 - 29 March 2017, vol.52, (Summary Text) identifier

141. Bir üniversite hastanesi kan merkezine başvuran kan bağışçılarının tarama test sonuçlarının değerlendirilmesi n

Yıldırım İ. G., Yaşar E., Önal A. E., Baran A., Gülle B. T., Beşışık S.
19. Ulusal Halk Sağlığı Kongresi, Antalya, Turkey, 15 - 19 March 2017, vol.1, pp.301, (Summary Text)

142. Agressive Follicular Variant of Papillary Microcarcinoma Presenting with Extensive Bone Metastases and Associated with Weird Thyroid Function Tests

GÜL N., HACİŞAHİNOĞULLARI H., MESTANZADE M., KUBAT ÜZÜM A., SOYLUK SELÇUKBİRİCİK Ö., BEŞIŞIK S., et al.
Endo Bridge 2016, Antalya, Turkey, 20 - 23 October 2016, (Summary Text)

143. Lenalidomid ilişkili hipersensitivite reaksiyonlarında desensitizasyon deneyimi

DEMİR N., DEMİR S., ÖZKAN S. G., ERDEM S., ARSLAN Ö., NALÇACI M., et al.
42. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 19 October 2016, (Summary Text)

144. IMPACT OF STABLE DISEASE OR BETTER RESPONSES TO LENALIDOMIDE ON SURVIVAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: MCL-001 (EMERGE) AND MCL-002 (SPRINT) STUDIES

Goy A., Arcaini L., Williams M. E., Lamy T., Besisik S., Drach J., et al.
21st Congress of the European-Hematology-Association, Copenhagen, Denmark, 9 - 12 June 2016, vol.101, pp.477, (Summary Text) identifier

145. Investigation of gene expression of myeloma cells in bone marrow of multiple myeloma patients by transcriptome analysis

Sarıman M., SIRMA EKMEKCİ S., ABACI N., ÇAKİRİS A., PAÇAL F., ÜSTEK D., et al.
ESHG 2016, Barcelona, Spain, 21 - 24 May 2016, pp.153, (Full Text)

146. Hematopoetik Kök Hücre Nakli Başarısı üzerine HLA-DPB1 Uyumunun Etkisi

KANTARCIOĞLU B., BEKÖZ H. S., YÖNAL HİNDİLERDEN İ., KIVANÇ D., ÖĞRET Y., BEŞIŞIK S., et al.
Türk Hematoloji Derneği 9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavi Kongresi, Antalya, Turkey, 05 March 2016, (Full Text)

147. KİMERİZM ANALİZİ İÇİN SHORT TANDEM REPEAT-PCR VE KANTİTATİF-REAL TIME PCR YÖNTEMLERİNİN KARŞILAŞTIRILMASI

Abatay F., YÖNAL HİNDİLERDEN İ., ÖGRET Y., BEŞIŞIK S., OĞUZ F.
9. Ulusal Kemik İliği Transplantasonu ve Kök Hücre Tedavileri Kongresi, Antalya, Turkey, 3 - 05 March 2016, pp.136, (Summary Text)

148. Kronik miyeloid lösemili hastada tirozin kinaz inhibitörü kullanımı seyrinde gelişen dev hücreli arterit; istenmeyen etki mi rastlantı mı?

ÖZKAN S. G., DEMİR N., ARSLAN Ö., ERDEM S., TOZ B., ARTIM ESEN B., et al.
41. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 21 October 2015, (Summary Text)

149. RAPID EFFICACY OF LENALIDOMIDE PLUS DEXAMETHASONE FOR POEMS SYNDROME: ASSESSMENT OF FOUR PATIENT'S CLINICAL OUTCOME

Kalayoglu-Besisik S., Ayer M., Osmanbasoglu E., Torun E. S., Arslan O., Dogan O.
20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.747, (Summary Text) identifier

150. POST-AUTHORIZATION SAFETY OF LENALIDOMIDE plus DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EARLY SAFETY REPORT OF TURKISH PASS STUDY

Tuglular A. T. F., Pehlivan M., Sari H. I., Ayyildiz M. O., Saydam G., Sonmez M., et al.
20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.734, (Summary Text) identifier

151. Recombination frequencies in HLA loci among Turkish patients with hematological malignancies and theirfamily based donors.

KEKİK ÇINAR Ç., KARAHAN G., KAYA İ. A., BEŞIŞIK S., OĞUZ F.
ASBMT Tandem Meetins Uluslar arası Sempozyum (Üçüncü), Ankara, Turkey, 27 - 28 March 2015, pp.1, (Full Text)

152. Hematopoetik kök hücre nakli (HKHN) yapılan hastalardaki infeksiyonlardan sorumlu bakterilerin değerlendirilmesi

Hızmalı L., Başaran S., Yavuz S., Çağatay A. A., Özsüt H., Beşışık S., et al.
KLİMİK 2015 XVII. TÜRK KLİNİK MİKROBİYOLOJİ VE İNFEKSİYON HASTALIKLARI KONGRESİ, Antalya, Turkey, 25 - 29 March 2015, pp.297-298, (Summary Text)

153. The impact of donor specific anti-HLA antibodies on the outcome of allogeneic stem cell transplantation

Kekik Ç., Yonal-Hindilerden I., Savran-Oguz F., Usta S., Temurhan S., Batu-Demir D., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, (Summary Text) identifier

154. HLA-A allele mismatch (7/8 or 9/10) is the second best option after 8/8 or 10/10 matched unrelated donors: An analysis on results from Turkish centers

Beksac M., Oguz F., Topcuoglu P., Karasu G., Arat M., Aksoylar S., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, (Summary Text) identifier

155. Primary Adrenal Lymphoma As A Rare Cause Of Unilateral Adrenal Mass

GÜL N., KUBAT ÜZÜM A. K., ARAL F., BEŞIŞIK S., ALAGÖL M. F., TANAKOL R.
Endo Bridge 2014, Antalya, Turkey, 23 - 26 October 2014, pp.29, (Summary Text)

156. RESTORING OF DONOR CHIMERISM BY THYROSINE KINASE INHIBITOR TREATMENT IN RELAPSED CHRONIC MYELOID LEUKEMIA AFTER ALLOGENIC TRANSPLANTATION

Ogret Y., Erkek E., Osmanbasoglu E., Yonal I., Ogret Y., Oguz F. S., et al.
28th EFI European Immunogenetics and Histocompatibility Conference, Stockholm, Sweden, 25 - 28 June 2014, vol.84, pp.56, (Summary Text) identifier

157. INVESTIGATION OF LINEAGE-SPECIFIC AND PERIPHERAL BLOOD CHIMERISM ANALYSIS IN POST-STEM CELL TRANSPLANT PATIENTS

Ogret Y., Oguz F. S., Besisik S., Sargin D.
28th EFI European Immunogenetics and Histocompatibility Conference, Stockholm, Sweden, 25 - 28 June 2014, vol.84, pp.55-56, (Summary Text) identifier

158. THE IMPACT OF DONOR SPECIFIC ANTI-HLA AND ANTI-GSTT1 ANTIBODIES ON THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION

Kekik C., Yonal I., Oguz F. S., Usta S., Temurhan S., Batu D., et al.
28th EFI European Immunogenetics and Histocompatibility Conference, Stockholm, Sweden, 25 - 28 June 2014, vol.84, pp.56-57, (Summary Text) identifier

159. The association of HLA alleles with oral mucositis severity and frequency in allogeneic hematopoietic stem cell transplant recipients.

Erdem A., Beşışık S., Oğuz F., Tufan F., Çınar Ç., Tarakçı F., et al.
Best of ASBMT Tandem Meetins Uluslararası Sempozyum, Ankara, Turkey, 21 - 22 March 2014, pp.2, (Summary Text)

160. Allogegneik kök hücre nakli sonrası anti-HLA ve anti-GSTT1 antikorlarının nakil başarısı üzerine etkisi.

YÖNAL HİNDİLERDEN İ., ÇINAR Ç., OĞUZ F., AKGÜL S., TEMURHAN S., BATU DEMİR D., et al.
8. Ulusal Kemik İliği Transplantasyonu ve Kök hücre tedavileri kongresi, Antalya, Turkey, 6 - 08 March 2014, pp.153-154, (Full Text)

161. IMPACT OF GLUTATHIONE S-TRANSFERASE AND CYTOCHROME P450 POLYMORPHISMS ON CLINICAL OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TANSPLANTATION

Bozbey H. U., Kalayoglu-Besisik S., Akgul S., Oguz F., Sargin D.
40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, Italy, 30 March - 02 April 2014, vol.49, (Summary Text) identifier

162. CHIMERISM STATUS AND ITS EFFECT ON CLINICAL OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TANSPLANTATION

Osmanbasoglu E., Kalayoglu-Besisik S., Ogret Y., Oguz F., Sargin D.
40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, Italy, 30 March - 02 April 2014, vol.49, (Summary Text) identifier

163. Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib

Goy A., Williams M. E., Besisik S., Drach J., Ramchandren R., Robertson M. J., et al.
55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122, (Summary Text) identifier

164. Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.

ELVERDİ T., TEMURHAN S., OSMANBAŞOĞLU E., AKGÜL S., AYDIN F., NALÇACI M., et al.
4 th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 22 - 25 May 2013, pp.310-311, (Full Text)

165. Lenalidomide in relapsed/refractory mantle cell lymphoma post-bortezomib: Subgroup analysis of the MCL-001 study

Williams M. E., Goy A., Sinha R., Besisik S., Drach J. W., Ramchandren R., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text) identifier

166. Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma

Witzig T. E., Vose J., Zinzani P. L., Habermann T. M., Tuscano J. M., Sinha R., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text) identifier

167. Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 "EMERGE" Study

Goy A., Sinha R., Williams M. E., Besisik S., Drach J., Ramchandren R., et al.
54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 8 - 11 December 2012, vol.120, (Summary Text) identifier

168. TYPING OF RELATIVES OF PATIENTS BEING CONSIDERED FOR ALLOGENEIC STEM CELL TRANSPLANTATION

Oguz F., Besisik S., Kekik C., Karahan G. E., Temurhan S., Usta S., et al.
Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, United Kingdom, 31 May - 03 June 2012, vol.79, pp.441-442, (Summary Text) identifier

169. How did the sibling donor's manage their lives?: a 13-year follow-up survey on the impact of giving stem cell

Tarakci-Bilgin F., Kobak A., Dinckoklu O., Gullu F., Uysal S., Sargin D., et al.
38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, Switzerland, 1 - 04 April 2012, vol.47, (Summary Text) identifier

170. Effect of HLA allels on graft-versus-host disease occurrence in Turkish patients receiving a human leukocyte antigen-identical haematopoietic stem cell transplant

Muftuoglu M., Gurses-Koc N., Savran-Oguz F., Sargin D., Kalayoglu-Besisik S.
38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, Switzerland, 1 - 04 April 2012, vol.47, (Summary Text) Sustainable Development identifier

171. Bacillus cereus Catheter Related Bloodstream Infection in a Patient with Acute Lymphoblastic Leukemia

GÜRLER N., ÖKSÜZ L., MÜFTÜOĞLU M., SARGIN F. D., BESISIK S.
8th International Symposium on Antimicrobial Agents and Resistance (ISAAR), Seul, South Korea, 6 - 08 April 2011, pp.292, (Full Text)

172. The evaluation of the incidence of recurrent aphthous lesions in patients with haematinic deficiencies

KORAY M., OFLUOĞLU D., OFLUOĞLU D., ERDEN S., ÖZGÜL M., kalayoğlu S., et al.
10th Biennial Conference of EAOM Incorporating the World Workshop on Oral Medicine, United Kingdom, (Full Text)

173. Multiple myeloma hastalarında sitokin gen polimorfizmi ve 13. kromozom delesyonu.

ÇINAR Ç., KARAHAN G. E., SEYHUN Y., TEMURHAN S., BEŞIŞIK S., OĞUZ F., et al.
1.Ulusal Lenfoma-myeloma Kongresi, Antalya, Turkey, 20 - 23 May 2010, pp.130, (Full Text)

174. Miyeloid Lösemilerde Kromozomal Anomaliler.

Özdilli K., AYDIN F., OĞUZ F., TEMURHAN S., Çako Ö., BEŞIŞIK S.
XI. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 28 - 31 October 2009, pp.57-58, (Full Text)

175. İstanbul Tıp Fakültesi Kemik İliği Bankası (İTF KİBANK).

OĞUZ F., ÇINAR Ç., KARAHAN G. E., TEMURHAN S., ÖGRET Y., BEŞIŞIK S., et al.
35. Ulusal Hematoloji Kongresi, Antalya, Turkey, 7 - 10 October 2009, pp.1-2, (Full Text)

176. Akut Miyeloid Lösemide Kromozom Anormalliklerin Sıklığı Yaşla ve Cinsiyetle Değişir mi?

Özdilli K., AYDIN F., BEŞIŞIK S., ÖNAL A. E., TEMURHAN S., KARAHAN G. E., et al.
X. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 6 - 09 September 2007, pp.223, (Full Text)

177. Does the frequency of chromosomal aberrations change with age and gender in acute myeloid leukemia?

Aydin F., Özdilli K., Kalayoglu S., Onal A. E., Temurhan S., Karahan G. E., et al.
21st European Immunogenetics and Histocompatibility Conference, Barcelona, Spain, 5 - 08 May 2007, vol.69, pp.461, (Summary Text) identifier

178. Variant Philadelphia translocations in patients with Chronic Myeloid Leukemia

Aysegul B., Ali U., Sukru P., Sukru O., Kivanc C., Gulcin B., et al.
6th European Cytogenetics Conference, İstanbul, Turkey, 7 - 10 July 2007, pp.202, (Summary Text) identifier

179. Does previous interferon use have negative effect on imatinib response in chronic myeloid leukemia (CML)? A single center study.

Yenerel M. N., Diz-Kucukkaya R., Demirel N., Ayer M., Yavuz S., Besisik S., et al.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text) identifier

180. Determination of cytokine gene polymorphisms in patients with multiple myeloma

Kekik Ç., Besisik S., Oguz S. F., Seyhun Y., Karahan G., Gurtekin M., et al.
20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.542-543, (Summary Text) identifier

181. Tissue chimerism studies can identify the source of cell population composing extramedullar leukemic infiltration during medullar remission

Besisik S., Oguz S. F., Aydin F., Ogret Y., Sargin D., Carin M.
20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.498, (Summary Text) identifier

182. HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma

Oguz F., Kalayoglu S., Erer B., Kekik Ç., Ozturk G., Carin M., et al.
20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.533-534, (Summary Text) identifier

183. The incidence of Ph chromosome and Trisomy 8 in chronic myeloid patients

Aydin F. A., Özdilli K., Kalayoglu S., Oguz F., Temurhan S., Carin M. N., et al.
20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 8 - 11 June 2006, vol.67, pp.548-549, (Summary Text) identifier

184. Allogeneik Kök Hücre Nakli Sonrası Kimerizmin Değerlendirilmesinde FISH ve STR-PCR Yöntemleri.

AYDIN F., BEŞIŞIK S., OĞUZ F., ÖGRET Y., TEMURHAN S., SARGIN F. D., et al.
IX. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Manisa, Turkey, 24 - 27 November 2005, pp.115, (Full Text)

185. Allojenik hematopoetik kök hücre naklinden sonra GVHH ve minör H antijenleri arasındaki ilişki

Çınar Ç., Beşışık S., Oğuz F., Seyhun Y., Sargın D., Çarin M.
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Turkey, 24 - 27 November 2005, (Summary Text)

186. The association between HLA markers and oral mucositis in allogeneic hematopoietic cell transplantation

Kalayoglu-Besisik S., Caliskan Y., Oguz F., Sargin D., Carin M.
19th European Immunogenetics and Histocompatibility Conference, İstanbul, Turkey, 23 - 26 April 2005, vol.6, (Summary Text) identifier

187. Chimerism monitoring by short tandem repeat (STR) analysis in HSCT

Duvarci Y., Oguz F., Besisik S., Sargin D., Carin M.
19th European Immunogenetics and Histocompatibility Conference, İstanbul, Turkey, 23 - 26 April 2005, vol.6, (Summary Text) identifier

188. The relationship between HLA antigens and CMV infection after HSCT: A single center experience from Turkey

Kekik Ç., Kalayoglu-Besisik S., Seyhun Y., Savran-Oguz F., Sargin D., Carin M.
19th European Immunogenetics and Histocompatibility Conference, İstanbul, Turkey, 23 - 26 April 2005, vol.6, (Summary Text) identifier

189. The relationship between minor histocompatibility antigens and graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

Kekik Ç., Besisik S., Oguz F., Seyhun Y., Carin M., Sargin D.
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Czech Republic, 20 - 23 March 2005, vol.35, (Summary Text) identifier

190. The relationship between minor histocompatibility antigens and graft-versus-host disease after the allogeneic hematopoietic stem cell transplantation

Kekik Ç., Besisik S., Oguz F., Seyhun Y., Carin M.
18th European Histocompatibility Conference, Sofija, Bulgaria, 8 - 11 May 2004, vol.5, (Summary Text) identifier

191. The negative impact of stem cell transplantation on psychological status; a single-centre experience

Bilgin F., Akgul N., Paroz B., Akgul A., Yildirim N., Cayir N., et al.
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33, (Summary Text) identifier

192. Incidence and outcome of renal dysfunction early in the course of haematopoietic cell transplantation

Caliskan Y., Besisik S., Sargin D., Ecder T.
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33, (Summary Text) identifier

193. Quality of life assessment of haematopoietic stem cell transplantation patients in Istanbul: a pilot study

Cetiner M., Kalaca S., Ratip S., Yazgan C., Adiguzel C., Kalayoglu-Besisik S., et al.
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, Spain, 28 - 31 March 2004, vol.33 identifier

194. The association of HLA class I antigens and class II alleles with multiple myeloma in Turkey.

Kalayoglu-Besisik S., Erer B., Savran-Oguz F., Yucel S., Erten N., Yenerel M. N., et al.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text) identifier

195. Oral lesions and hygiene in stem cell recipients with graft versus host disease.

Kalayoglu-Besisik S., Ak G., Koray M., Savran-Oguz F., Sargin D., Tanyeri H.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text) identifier

196. Interleukin-6 gene polymorphisms associate with acute graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation

Gurses N., Kalayoglu-Besisik S., Sargin D., Ferhanoglu B., Anak S., Soysal T., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text) identifier

197. The effect of stem cell transplantation on social and economic status in a developing country on family basis

Turgut E., Kaftancioglu U., Cesur V., Akgul N., Esen B., Hancer V., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text) identifier

198. Change in serum procalcitonin has diagnostic and prognostic value for most early complications in stem cell transplantation

Besisik S., Cagatay Y., Oguz F., Cagatay A., Sargin D.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text) identifier

199. HLA full match donors

Kaftancioglu U., Turgut E., Hancer V., Cesur V., Akgul N., Esen B., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 identifier

200. What people having hematologic malignancies and people of good health think about infertility

Akgul N., Esen B., Bilgin F., Akgul A., Cayir N., Yildirim N., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31 Sustainable Development identifier

201. Unrelated hematopoietic stem cell transplantation: Istanbul University/Istanbul medical faculty bone marrow registry (Kibank): a pioneering role in turkey

Diler A., Oguz F., Besisik S., Sargin D., Anak S., Carin M.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text) identifier

202. Effect of methylenetetrahydrofolate reductase gene polymorphism on methotrexate toxicity after bone marrow transplantation

BESISIK S., GURSES N., CALISKAN Y., TARAKCI F., ÇİNE N., Aydin M., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text) identifier

203. Extracorporeal photoimmunotherapy for treatment of steroid refractory extensive chronic graft versus host disease: Turkish experience

Ilhan O., Kalayoglu S., Unal A., Arat M., Arslan O., Sargin D., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Turkey, 23 - 26 March 2003, vol.31, (Summary Text) identifier

204. Procalcitonin in stem cell transplantation: It has highly diagnostic and prognostic value for most early complications.

Cagatay Y., Besisik S., Seyhun Y., Oguz F., Cagatay A., Turan O., et al.
44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 December 2002, vol.100, (Summary Text) identifier

205. t(15;17) Translokasyonlu Akut Promyelositik Lösemili Hastalarda RT-PCR Yöntemiyle Minimal Rezidüel Hastalık Takibi

Bayrak A. E., Sırma Ekmekci S., Beşışık S., Başlar Z., Kandilci A., Yalman N., et al.
XXVIII. Ulusal Hematoloji Kongresi, İzmir, Turkey, 1 - 04 November 2000, pp.221, (Summary Text)

206. Association of HLA-DR alleles with acute leukemias and aplastic anemia in Turkish population

Oğuz F., Kılıçarslan T., Diler A., Çınar Ç., Seyhun Y., Oğuz R., et al.
14th EFI Conference, Montpellier, France, 4 - 07 April 2000, pp.159, (Summary Text)
Books 18

1. OLGULARLA TRANSFÜZYON BULMACALARI

Beşışık S.
in: Acil Dahiliye, Kerim Güler,Semra Çalangu, Editor, Nobel Yayın Dağıtım, İstanbul, pp.1-2, 2025

2. Acil Polikliniğe Başvuran Hastalarda Hemogramın Değerlendirilmesi

Beşışık S.
in: Dahili - Cerrahi - Adli -Aciller El Kitabı, rof. Dr. Mehmet Şükrü Sever,Doç. Dr. Halil Yazıcı,Pof. Dr. Tevfik Ecder, Editor, Nobel Yayın Dağıtım, İstanbul, pp.555-587, 2024

3. Kalp Transplantasyonunda Güncel Yaklaşımlar - 2023

Beşışık S., Tor Y. B.
Türkiye Klinikleri Yayınevi, Ankara, 2023

4. Kalp Transplantasyonunda Güncel Hematolojik İzlem ve Yaklaşımlar

Tor Y. B., Beşışık S.
in: Kalp Transplantasyonunda Güncel Yaklaşımlar, Nilgün Bozbuğa, Editor, Türkiye Klinikleri, Ankara, pp.142-149, 2023

5. Herediter Plazminojen Eksikliği İlişkili Lignöz Konjonktivit

TUĞCU D., ŞAHİN Ş., YILMAZ Y., BİLİCİ M., KARAMAN S., Baburoğlu M., et al.
in: Olgularla Kanayan Çocuk, Ayşegül Ünüvar, Canan Bayrak,Dilek Gökçebay, Elif Gürler Kazancı, Kahraman Öncel, Editor, Galenos, pp.35-41, 2023

6. Herediter Plazminojen Eksikliği İlişkili Lignöz Konjonktivit

TUĞCU D., ŞAHİN Ş., YILMAZ Y., BİLİCİ M., KARAMAN S., BARBUROĞLU M., et al.
in: OLGULARLA KANAYAN ÇOCUK, AYŞEGÜL ÜNÜVAR, CANAN ALBAYRAK, DİLEK GÜRLEK GÖKÇEBAY, ELİF GÜLER KAZANCI, KAHRAMAN ÖNCEL, Editor, GALENOS, İstanbul, pp.35-40, 2023

7. MULTIPLE MYELOMA AND IMMUNE MODULATORS

Çalıcı Kıyak E., Şentürk Çiftçi H., Oğuz F., Beşışık S.
Livre.net , Lyon, 2022

8. HEMATOLOJİK HASTALIKLARDA ORAL DİAGNOZ

Beşışık S.
in: Multidisipliner Prensiplerle Oral Diagnoz, İlknur Özcan, Editor, İstanbul Tıp Kitapevi, İstanbul, pp.150-153, 2022

9. Kanama ve Koagülasyon Bozuklukları

BEŞIŞIK S., ERDEM S.
in: TRAVMA, Cemalettin ERTEKİN, Editor, EMA Tıp Kitabevi Yayıncılık Tic. Ltd. Şti., İstanbul, pp.1326-1332, 2022

10. MULTIPLE MYELOMA AND IMMUNE MODULATORS

Gürer E. E., ŞENTÜRK ÇİFTÇİ H., OĞUZ F., BEŞIŞIK S.
in: Advances in Medicine and Health Science Researches and Practice, Prof. Dr. Halit DEMİR Asst. Prof. Dr. Mehmet Okan DONBALOĞLU, Editor, by Livre de Lyon, Lyon, pp.103-110, 2022

11. Hodgkin Dışı Lenfomalarda Hedefe Yönelik Tedaviler

Erdem S., Beşışık S.
in: Hematolojik Kanserlerde Hedefe Yönelik Tedaviler, İlhami Kiki, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.35-44, 2021 Sustainable Development

12. Anemi

Beşışık S.
in: Geriatri Yaşlı Sağlığı ve Hastalıkları, Prof. Dr. Zekeriya Ülger Prof. Dr. Ü. Deniz Erdinçler Prof. Dr. Mehmet Akif Karan, Editor, HİPOKRAT, Ankara, pp.1-14, 2021 Creative Commons License

13. Endotel Hastalıkları ve Hematolojik Komplikasyonlar

Güzel Mastanzade M., Beşışık S.
in: İmmünohematolojide Güncel Başlıklar, Gülsan Türköz Sucak, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.25-30, 2021

14. Hodgkin Dışı Lenfomalarda Hedefe Yönelik Tedaviler

ERDEM S., BEŞIŞIK S.
in: HEMATOLOJİK KANSERLERDE HEDEFE YÖNELİK TEDAVİLER, KİKİ İLHAMİ, Editor, Türkiye Klinikleri Hematoloji, Ankara, pp.35-44, 2021 Sustainable Development

15. Halk Sağlığı ve COVID-19 - 2020, Convalescent (Immune) Plasma Therapy in COVID-19

Beşışık S., Yanaşık M., Beşışık Terzioğlu M. B.
Ankara Üniversitesi, Ankara, 2020 Sustainable Development

16. COVID-19'da Hematolojik Bulgular

Tor Y. B., Mastanzade M., Beşışık S.
in: Halk Sağlığı ve COVID-19, Önal AE, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.56-60, 2020 Sustainable Development

17. Multipl Miyelomda Böbrek Hastalığına Tedavi Yaklaşımı

ERDEM S., BEŞIŞIK S.
in: Türkiye Klinikleri Hematoloji, Multipl Miyelom Özel Sayısı, GÖKER HAKAN, Editor, Türkiye Klinikleri Hematoloji, Ankara, pp.53-58, 2019

18. TÜRKİYE’DE MULTİPL MYELOM’LU HASTALARDA GLUTATYON-S-TRANSFERAZ VE SİTOKROM P450 ENZİMİ GEN POLİMORFİZMİ İLİŞKİSİ

Sarybayev M., Beşışık S.
Uzmanlık Tezi, İstanbul, 2013 Creative Commons License
Metrics

Publication

429

Publication (WoS)

250

Publication (Scopus)

180

Citation (WoS)

1131

H-Index (WoS)

16

Citation (Scopus)

1279

H-Index (Scopus)

19

Citation (Scholar)

81

H-Index (Scholar)

5

Citation (TrDizin)

4

H-Index (TrDizin)

1

Citation (Sum Other)

4

Total Citation Count

1139

Project

15

Thesis Advisory

16

Open Access

15
UN Sustainable Development Goals